The proteasomal system.

Rising interest in the mechanism and function of the proteasomes and the ubiquitin system revealed that it is hard to find any aspect of the cellular metabolic network that is not directly or indirectly affected by the degradation system. This includes the cell cycle, the "quality control" of newly synthesized proteins (ERAD), transcription factor regulation, gene expression, cell differentiation, immune response or pathologic processes like cancer, neurodegenerative diseases, lipofuscin formation, diabetes, atherosclerosis, inflammatory processes or cataract formation and in addition to that the aging process itself and the degradation of oxidized proteins, in order to maintain cell homeostasis. But also this seems to be only a small aspect of the general view. The various regulator proteins that are able to change the rate or specificity of proteolysis, fitting it out for highly specialized tasks, or the precise regulation of the half-life of cellular proteins by ubiquitin-mediated degradation shape the proteasome and the ubiquitin-proteasome system into a fascinating and essential part of cellular function in the three kingdoms of bacteria, plants and animals. This review tries to summarize the current knowledge on the proteasome and the ubiquitin-proteasomal system, including the cellular functions of this system.

[1]  P. Elliott,et al.  Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. , 2001, International journal of radiation oncology, biology, physics.

[2]  N. Chondrogianni,et al.  Proteasome activation as a novel antiaging strategy , 2008, IUBMB life.

[3]  S. Hayashi Antizyme-dependent degradation of ornithine decarboxylase. , 1995, Essays in biochemistry.

[4]  K. Schwarz,et al.  Immunoproteasomes Largely Replace Constitutive Proteasomes During an Antiviral and Antibacterial Immune Response in the Liver1 , 2001, The Journal of Immunology.

[5]  R. Derynck,et al.  Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  F. Tortella,et al.  Neuroprotection with the proteasome inhibitor MLN519 in focal ischemic brain injury: Relation to nuclear factor κB (NF-κB), inflammatory gene expression, and leukocyte infiltration , 2006, Neurochemistry International.

[7]  P. Kinnunen,et al.  Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). , 2001, European journal of biochemistry.

[8]  S. Matsufuji,et al.  Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination , 1992, Nature.

[9]  X. Zou,et al.  The Two ATP Binding Sites of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Play Distinct Roles in Gating Kinetics and Energetics , 2006, The Journal of general physiology.

[10]  W. Markesbery,et al.  Impaired Proteasome Function in Alzheimer's Disease , 2000, Journal of neurochemistry.

[11]  D. Haines,et al.  Cdc48p(Npl4p/Ufd1p) binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors. , 2007, Molecular cell.

[12]  A. Kisselev Joining the army of proteasome inhibitors. , 2008, Chemistry & biology.

[13]  J. Tobias,et al.  The N-end rule in Escherichia coli: cloning and analysis of the leucyl, phenylalanyl-tRNA-protein transferase gene aat , 1993, Journal of bacteriology.

[14]  J. Brodsky,et al.  Dissecting the ER-Associated Degradation of a Misfolded Polytopic Membrane Protein , 2008, Cell.

[15]  Patricia A. Pioli,et al.  The Von Hippel-Lindau Protein Interacts with Heteronuclear Ribonucleoprotein A2 and Regulates Its Expression* , 2001, The Journal of Biological Chemistry.

[16]  I. Mook‐Jung,et al.  Amyloid peptide attenuates the proteasome activity in neuronal cells , 2005, Mechanisms of Ageing and Development.

[17]  Michele Pagano,et al.  SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. , 2006, Molecular cell.

[18]  B. Seilheimer,et al.  Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis‐like disease , 2006, Journal of neuroscience research.

[19]  J. Monaco,et al.  T Cells Lacking Immunoproteasome Subunits MECL-1 and LMP7 Hyperproliferate in Response to Polyclonal Mitogens1 , 2006, The Journal of Immunology.

[20]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[21]  J. Freedman,et al.  A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation. , 1998, The Biochemical journal.

[22]  R. Youle,et al.  Outer Mitochondrial Membrane Protein Degradation by the Proteasome , 2007 .

[23]  K. Davies,et al.  Dityrosine: a marker for oxidatively modified proteins and selective proteolysis. , 1994, Methods in enzymology.

[24]  B. Friguet,et al.  Enzymatic reactions involved in the repair of oxidized proteins , 2004, Experimental Gerontology.

[25]  B. Friguet,et al.  Algae extract-mediated stimulation and protection of proteasome activity within human keratinocytes exposed to UVA and UVB irradiation. , 2006, Antioxidants & redox signaling.

[26]  K. Davies,et al.  4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease* , 2000, Cellular and Molecular Life Sciences CMLS.

[27]  J. Slack,et al.  Identification of proteassemblin, a mammalian homologue of the yeast protein, Ump1p, that is required for normal proteasome assembly. , 2000, Molecular cell biology research communications : MCBRC.

[28]  W. Miller,et al.  Retinoic acid mediates degradation of IRS-1 by the ubiquitin–proteasome pathway, via a PKC-dependant mechanism , 2004, Oncogene.

[29]  M. Angeletti,et al.  Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems. , 2003, Free radical biology & medicine.

[30]  S. Itohara,et al.  Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model. , 2004, Human molecular genetics.

[31]  M. Tuite,et al.  Protein disulphide isomerase: building bridges in protein folding. , 1994, Trends in biochemical sciences.

[32]  L. Hendershot,et al.  BiP mutants that are unable to interact with endoplasmic reticulum DnaJ proteins provide insights into interdomain interactions in BiP , 2008, Proceedings of the National Academy of Sciences.

[33]  Richard Weindruch,et al.  Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Hubert Kimmig,et al.  Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17) , 2007, Neurology.

[35]  G N DeMartino,et al.  Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome). , 1991, Biochemistry.

[36]  R. Tennant,et al.  Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation. , 2008, Journal of molecular biology.

[37]  S. Elledge,et al.  Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.

[38]  P. Crack,et al.  Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. , 2008, Current medicinal chemistry.

[39]  A. Nunomura,et al.  Oxidative damage in Alzheimer’s disease: the metabolic dimension , 2000, International Journal of Developmental Neuroscience.

[40]  Lars I Leichert,et al.  Protein Thiol Modifications Visualized In Vivo , 2004, PLoS biology.

[41]  Yoram Louzoun,et al.  Precise score for the prediction of peptides cleaved by the proteasome , 2008, Bioinform..

[42]  L. Claesson‐Welsh,et al.  Expression of Growth Factors and Growth Factor Receptors in Capillary Hemangioblastoma , 1996, Journal of neuropathology and experimental neurology.

[43]  Martin Rechsteiner,et al.  Recognition of the polyubiquitin proteolytic signal , 2000, The EMBO journal.

[44]  P. Mcgeer,et al.  Chymotrypsin‐like proteases contribute to human monocytic THP‐1 cell as well as human microglial neurotoxicity , 2005, Glia.

[45]  M. Rechsteiner,et al.  Are Huntington's and polyglutamine-based ataxias proteasome storage diseases? , 2003, The international journal of biochemistry & cell biology.

[46]  K. Tanaka,et al.  The NH2‐terminal residues of rat liver proteasome (multicatalytic proteinase complex) subunits, C2, C3 and C8, are Nα‐acetylated , 1990, FEBS Letters.

[47]  D. Butterfield,et al.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71 , 2002, Journal of neurochemistry.

[48]  W. Markesbery,et al.  Proteasome inhibition results in increased poly‐ADP‐ribosylation: Implications for neuron death , 2000, Journal of neuroscience research.

[49]  M. Stitzel,et al.  The proteasome regulates the UV-induced activation of the AP-1-like transcription factor Gcn4. , 2001, Genes & development.

[50]  R. Tampé,et al.  Intracellular peptide transporters in human – compartmentalization of the “peptidome” , 2007, Pflügers Archiv - European Journal of Physiology.

[51]  A. Goldberg,et al.  The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator. , 1996, European journal of biochemistry.

[52]  U. Aebi,et al.  The Human α-Type Proteasomal Subunit HsC8 Forms a Double Ringlike Structure, but Does Not Assemble into Proteasome-like Particles with the β-Type Subunits HsDelta or HsBPROS26* , 1997, The Journal of Biological Chemistry.

[53]  Y. Murakami,et al.  Hybrid Proteasomes , 2000, The Journal of Biological Chemistry.

[54]  B. Keller,et al.  Cu/Zn Superoxide Dismutase Typical for Familial Amyotrophic Lateral Sclerosis Increases the Vulnerability of Mitochondria and Perturbs Ca2+ Homeostasis in SOD1G93A Mice , 2009, Molecular Pharmacology.

[55]  Y. Murakami,et al.  ATP- and antizyme-dependent endoproteolysis of ornithine decarboxylase to oligopeptides by the 26 S proteasome. , 1994, The Journal of biological chemistry.

[56]  U. Brunk,et al.  Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.

[57]  V. Pérez,et al.  Proteasome modulates mitochondrial function during cellular senescence. , 2008, Free radical biology & medicine.

[58]  P. Lansbury,et al.  Reversible Monoubiquitination Regulates the Parkinson Disease-associated Ubiquitin Hydrolase UCH-L1*♦ , 2007, Journal of Biological Chemistry.

[59]  R. Eckel,et al.  Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes. , 2002, Circulation.

[60]  Günter J. Hämmerling,et al.  Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex , 1991, Nature.

[61]  D. Price,et al.  Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues , 2001, Neurobiology of Disease.

[62]  Claudine Jurkovitz,et al.  Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. , 1999, American journal of physiology. Cell physiology.

[63]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[64]  J. White,et al.  Proteasome Activator PA200 Is Required for Normal Spermatogenesis , 2006, Molecular and Cellular Biology.

[65]  E. Mazzon,et al.  Protective effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in paw oedema induced by carrageenan in the rat. , 1999, Biochemical pharmacology.

[66]  K. Anderson,et al.  Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. , 2006, Blood.

[67]  Mark R. Segal,et al.  Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.

[68]  T. Kodadek,et al.  The proteasomal ATPase complex is required for stress-induced transcription in yeast , 2006, Nucleic acids research.

[69]  D. Masison,et al.  Prion-impairing mutations in Hsp70 chaperone Ssa1: effects on ATPase and chaperone activities. , 2008, Archives of biochemistry and biophysics.

[70]  U. Brunk,et al.  Oxidative stress, accumulation of biological 'garbage', and aging. , 2006, Antioxidants & redox signaling.

[71]  M. Beal,et al.  Mitochondrial dysfunction and amyotrophic lateral sclerosis , 2006, Muscle & nerve.

[72]  M. Latterich,et al.  p97: The cell's molecular purgatory? , 2006, Molecular cell.

[73]  M. Portero-Otín,et al.  Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation , 2005, Journal of Biological Chemistry.

[74]  G. Stamp,et al.  Early Postnatal Death and Motor Disorders in Mice Congenitally Deficient in Calnexin Expression , 2002, Molecular and Cellular Biology.

[75]  J. Harris Release of a macromolecular protein component from human erythrocyte ghosts. , 1968, Biochimica et biophysica acta.

[76]  K. Hendil,et al.  Proteasome subunit zeta, a putative ribonuclease, is also found as a free monomer , 1999, Molecular Biology Reports.

[77]  D. Livingston,et al.  The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. , 1996, Genes & development.

[78]  D. Wolf,et al.  A genomic screen identifies Dsk2p and Rad23p as essential components of ER‐associated degradation , 2004, EMBO reports.

[79]  J. Buchner,et al.  Cns1 Is an Activator of the Ssa1 ATPase Activity* , 2004, Journal of Biological Chemistry.

[80]  A. Goldberg,et al.  Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. , 1995, The American journal of physiology.

[81]  K. Davies,et al.  Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1993, The Journal of biological chemistry.

[82]  Cam Patterson,et al.  Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Albert,et al.  Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.

[84]  A. Buchberger,et al.  Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation , 2005, Nature Cell Biology.

[85]  G. Paolisso,et al.  Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture. , 2007, Circulation research.

[86]  A. Manning,et al.  Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. , 1995, Journal of immunology.

[87]  K. Davies,et al.  Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome. , 1993, The Journal of biological chemistry.

[88]  D. Giugliano,et al.  Intermittent high glucose enhances ICAM‐1, VCAM‐1, E‐selectin and interleukin‐6 expression in human umbilical endothelial cells in culture: the role of poly(ADP‐ribose) polymerase , 2004, Journal of thrombosis and haemostasis : JTH.

[89]  A. Hershko,et al.  Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[90]  O. Sommerburg,et al.  Influence of DNA binding on the degradation of oxidized histones by the 20S proteasome. , 1999, Archives of biochemistry and biophysics.

[91]  T. Hirano,et al.  Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells. , 2000, Blood.

[92]  P. Lehner The calculus of immunity: quantitating antigen processing. , 2003, Immunity.

[93]  D. Butterfield,et al.  Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.

[94]  A. Rembach,et al.  Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS , 2004, Journal of neuroscience research.

[95]  P. van Endert,et al.  Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non‐lymphoid human tissues , 2008, Journal of cellular physiology.

[96]  C. Olanow,et al.  Proteasome inhibition causes nigral degeneration with inclusion bodies in rats , 2002, Neuroreport.

[97]  C. Ireland,et al.  Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity. , 2004, Journal of medicinal chemistry.

[98]  G. Wolf Lipofuscin, the age pigment. , 2009, Nutrition reviews.

[99]  R. Huber,et al.  Proteasome beta-type subunits: unequal roles of propeptides in core particle maturation and a hierarchy of active site function. , 1999, Journal of molecular biology.

[100]  R. Gavioli,et al.  Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit. , 2007, European journal of medicinal chemistry.

[101]  Daniel Offen,et al.  Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage , 2006, Neuroscience Letters.

[102]  Michael D. George,et al.  A protein conjugation system essential for autophagy , 1998, Nature.

[103]  K. Takahashi,et al.  TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087. , 2000, The Journal of antibiotics.

[104]  K. Pelin,et al.  Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.

[105]  R. Kopito,et al.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis. , 2002, The Journal of clinical investigation.

[106]  Manuela M. Santos,et al.  Gene expression profiling in frataxin deficient mice: Microarray evidence for significant expression changes without detectable neurodegeneration , 2006, Neurobiology of Disease.

[107]  D. Spasic,et al.  Rer1p competes with APH-1 for binding to nicastrin and regulates γ-secretase complex assembly in the early secretory pathway , 2007, The Journal of cell biology.

[108]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[109]  P. Kloetzel,et al.  Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. , 2004, Current opinion in immunology.

[110]  Santanu Acharya,et al.  Bax and Bid act in synergy to bring about T11TS-mediated glioma apoptosis via the release of mitochondrial cytochrome c and subsequent caspase activation. , 2008, International immunology.

[111]  W. D. de Jong,et al.  The human proteasomal subunit HsC8 induces ring formation of other alpha-type subunits. , 1998, Journal of molecular biology.

[112]  M. Pagano,et al.  Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation , 1998, Molecular and Cellular Biology.

[113]  W. Mitch,et al.  Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. , 1994, The American journal of physiology.

[114]  B. Friguet,et al.  Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts , 2003, Journal of Biological Chemistry.

[115]  G. Kroemer,et al.  Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function , 1997, European journal of immunology.

[116]  J. Cooper Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. , 2003 .

[117]  K. Davies,et al.  Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part I— effects of proliferative senescence , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[118]  L. Lerman,et al.  Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease. , 2008, Journal of the American College of Cardiology.

[119]  J. Cusack,et al.  Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.

[120]  M. Atkins,et al.  Targeting the Mitogen-Activated Protein Kinase Pathway in the Treatment of Malignant Melanoma , 2006, Clinical Cancer Research.

[121]  P. Cresswell,et al.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.

[122]  S. Ommen,et al.  Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. , 2005, Molecular genetics and metabolism.

[123]  J. Sjöstrand,et al.  Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation. , 1999, Experimental eye research.

[124]  A. Parodi,et al.  Quality control and protein folding in the secretory pathway. , 2003, Annual review of cell and developmental biology.

[125]  A. Rivett,et al.  Purification of a liver alkaline protease which degrades oxidatively modified glutamine synthetase. Characterization as a high molecular weight cysteine proteinase. , 1985, The Journal of biological chemistry.

[126]  C. Masters,et al.  Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease , 2008 .

[127]  D. Green,et al.  Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. , 2000, Cancer research.

[128]  R. Sunahara,et al.  Regulation of cytochrome P450 2E1 by heat shock protein 90-dependent stabilization and CHIP-dependent proteasomal degradation. , 2005, Biochemistry.

[129]  M. Tatham,et al.  Polymeric Chains of SUMO-2 and SUMO-3 Are Conjugated to Protein Substrates by SAE1/SAE2 and Ubc9* , 2001, The Journal of Biological Chemistry.

[130]  J. Sarsero,et al.  Evaluation of an FRDA–EGFP genomic reporter assay in transgenic mice , 2005, Mammalian Genome.

[131]  F. Meyer,et al.  Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[132]  B Chance,et al.  The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. , 1973, The Biochemical journal.

[133]  R. Hampton,et al.  Determinants of RING-E2 Fidelity for Hrd1p, a Membrane-anchored Ubiquitin Ligase* , 2006, Journal of Biological Chemistry.

[134]  H. Sies Oxidative stress: from basic research to clinical application. , 1991, The American journal of medicine.

[135]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[136]  M. Muller,et al.  Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. , 2006, Free radical biology & medicine.

[137]  Yunbi Lu,et al.  Production of matrix metalloproteinase‐9 by activated human monocytes involves a phosphatidylinositol‐3 kinase/Akt/IKKα/NF‐κB pathway , 2005, Journal of leukocyte biology.

[138]  M. Molinari,et al.  Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER , 2002, The Journal of cell biology.

[139]  Aiqing He,et al.  The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[140]  B. Friguet,et al.  Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. , 1994, Archives of biochemistry and biophysics.

[141]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[142]  C. Hill,et al.  Identification of an activation region in the proteasome activator REGalpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[143]  P. Kloetzel,et al.  A theoretical approach towards the identification of cleavage-determining amino acid motifs of the 20 S proteasome. , 1999, Journal of molecular biology.

[144]  M. Koenig,et al.  Friedreich ataxia: the oxidative stress paradox. , 2005, Human molecular genetics.

[145]  Tilman Grune,et al.  Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains , 2006, Neurobiology of Aging.

[146]  Martin von Bergen,et al.  Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation. , 2007, Journal of the American Chemical Society.

[147]  G. Blair,et al.  Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins , 2000, Oncogene.

[148]  R. Klausner,et al.  The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[149]  H. Withers,et al.  Molecular Pathways That Modify Tumor Radiation Response , 2001, American journal of clinical oncology.

[150]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[151]  S. Wolff Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. , 1993, British medical bulletin.

[152]  K. Scharffetter-Kochanek,et al.  Psoralen plus UVA (PUVA) induced premature senescence as a model for stress-induced premature senescence , 2002, Experimental Gerontology.

[153]  Kenta Okamoto,et al.  Dissecting β‐ring assembly pathway of the mammalian 20S proteasome , 2008, The EMBO journal.

[154]  D. Butterfield,et al.  Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.

[155]  O. Mandelboim,et al.  Recruitment of MHC Class I Molecules by Tapasin into the Transporter Associated with Antigen Processing-Associated Complex Is Essential for Optimal Peptide Loading , 2002, The Journal of Immunology.

[156]  T. Montine,et al.  E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.

[157]  B. Friguet,et al.  Age-related alterations of proteasome structure and function in aging epidermis , 2000, Experimental Gerontology.

[158]  B. Friguet Protein Repair and Degradation during Aging , 2002, TheScientificWorldJournal.

[159]  B. Friguet,et al.  Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors. , 2008, Biochimie.

[160]  J. Remacle,et al.  Establishment of H2O2‐Induced Premature Senescence in Human Fibroblasts Concomitant with Increased Cellular Production of H2O2 , 2006, Annals of the New York Academy of Sciences.

[161]  M. Schmitz,et al.  NF-κB Inhibitors for the Treatment of Inflammatory Diseases and Cancer , 2007 .

[162]  M. Brownlee,et al.  Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. , 1990, Biochemical and biophysical research communications.

[163]  J. Andersen,et al.  Glutathione, iron and Parkinson's disease. , 2002, Biochemical pharmacology.

[164]  A. Rivett,et al.  Catalytic Properties of 26 S and 20 S Proteasomes and Radiolabeling of MB1, LMP7, and C7 Subunits Associated with Trypsin-like and Chymotrypsin-like Activities* , 1997, The Journal of Biological Chemistry.

[165]  G. Krissansen,et al.  Temporal Expression of Heat Shock Proteins 60 and 70 at Lesion-Prone Sites During Atherogenesis in ApoE-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[166]  H. Engelhard,et al.  Ciliary neurotrophic factor upregulates ubiquitin-proteasome components in a rat model of neuronal injury. , 2004, Cytokine.

[167]  M. Salmona,et al.  Protein Nitration in a Mouse Model of Familial Amyotrophic Lateral Sclerosis , 2005, Journal of Biological Chemistry.

[168]  P. Piccini,et al.  Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6) , 2005, Movement disorders : official journal of the Movement Disorder Society.

[169]  S. J. Upton,et al.  Cloning and Molecular Characterization of a Gene Encoding a Cryptosporidium parvum Putative 20s Proteasome β1—Type Subunit , 2000 .

[170]  J. Sastre,et al.  Glutathione Regulates Telomerase Activity in 3T3 Fibroblasts* , 2004, Journal of Biological Chemistry.

[171]  S. Humbert,et al.  Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic? , 2004, Pathologie-biologie.

[172]  L. Tutar,et al.  Ydj1 but not Sis1 stabilizes Hsp70 protein under prolonged stress in vitro , 2008, Biopolymers.

[173]  P. Kloetzel,et al.  The N-terminal Flanking Region of the TRP2360–368 Melanoma Antigen Determines Proteasome Activator PA28 Requirement for Epitope Liberation* , 2007, Journal of Biological Chemistry.

[174]  J. Ritz,et al.  Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. , 2001, Blood.

[175]  R. Rudolph,et al.  Catalytic Activity and Chaperone Function of Human Protein-disulfide Isomerase Are Required for the Efficient Refolding of Proinsulin* , 2002, The Journal of Biological Chemistry.

[176]  A. Koff,et al.  The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. , 2002, The Biochemical journal.

[177]  P. Elliott,et al.  Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[178]  P. Woodman p97, a protein coping with multiple identities , 2003, Journal of Cell Science.

[179]  C. Fan,et al.  A foldable CFTRΔF508 biogenic intermediate accumulates upon inhibition of the Hsc70–CHIP E3 ubiquitin ligase , 2004, The Journal of cell biology.

[180]  R. Wetzel,et al.  Solubilization and disaggregation of polyglutamine peptides , 2001, Protein science : a publication of the Protein Society.

[181]  Xin Eric Wang,et al.  Vitamin E and its function in membranes. , 1999, Progress in lipid research.

[182]  R. Huber,et al.  A gated channel into the proteasome core particle , 2000, Nature Structural Biology.

[183]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[184]  M. Hochstrasser,et al.  Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways , 2006, The EMBO journal.

[185]  P. Lansbury,et al.  Substrate recognition and catalysis by UCH-L1. , 2006, Biochemistry.

[186]  S. Kim,et al.  Essential Role of E2-25K/Hip-2 in Mediating Amyloid-β Neurotoxicity , 2003 .

[187]  A. Paolicchi,et al.  Glutathione catabolism as a signaling mechanism. , 2002, Biochemical pharmacology.

[188]  U. Brunk,et al.  Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. , 1997, Free radical biology & medicine.

[189]  P. Flakoll,et al.  Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. , 2002, The Journal of clinical investigation.

[190]  W. Xiao,et al.  The TRAF6 RING finger domain mediates physical interaction with Ubc13 , 2004, FEBS letters.

[191]  L. Lerman,et al.  Chronic Proteasome Inhibition Contributes to Coronary Atherosclerosis , 2007, Circulation research.

[192]  P. Howley,et al.  In vivo ubiquitination and proteasome-mediated degradation of p53(1). , 1996, Cancer research.

[193]  S. Fey,et al.  Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. , 2002, Biochemical pharmacology.

[194]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[195]  I. Grundke‐Iqbal,et al.  Phosphorylation of τ Protein by Casein Kinase‐1 Converts It to an Abnormal Alzheimer‐Like State , 1995, Journal of neurochemistry.

[196]  S. Orrenius,et al.  Redox regulation of apoptotic cell death , 1998, BioFactors.

[197]  F. Cognetti,et al.  Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. , 2000, Journal of experimental & clinical cancer research : CR.

[198]  M. Stanton,et al.  Cystic fibrosis mortality and survival in the UK: 1947–2003 , 2007, European Respiratory Journal.

[199]  L. Pasquini,et al.  Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase‐3 in cultured cerebellar granule cells , 2000, Journal of neuroscience research.

[200]  B. Friguet,et al.  Frataxin deficiency causes upregulation of mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe–S proteins , 2009, The FEBS journal.

[201]  R. Moon,et al.  Signal transduction through beta-catenin and specification of cell fate during embryogenesis. , 1996, Genes & development.

[202]  R. Brigelius-Flohé,et al.  Selenium-dependent enzymes in endothelial cell function. , 2003, Antioxidants & redox signaling.

[203]  Kenta Okamoto,et al.  Crystal structure of a chaperone complex that contributes to the assembly of yeast 20S proteasomes , 2008, Nature Structural &Molecular Biology.

[204]  M. Kasahara,et al.  Growth Retardation in Mice Lacking the Proteasome Activator PA28γ* , 1999, The Journal of Biological Chemistry.

[205]  C. Masters,et al.  Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease β‐amyloid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[206]  Richard S. Rogers,et al.  A conserved catalytic residue in the ubiquitin‐conjugating enzyme family , 2003, The EMBO journal.

[207]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[208]  J. Zieleński,et al.  Cystic fibrosis: genotypic and phenotypic variations. , 1995, Annual review of genetics.

[209]  J. Ávila,et al.  Extracellular tau is toxic to neuronal cells , 2006, FEBS letters.

[210]  J. Yewdell,et al.  Making sense of mass destruction: quantitating MHC class I antigen presentation , 2003, Nature Reviews Immunology.

[211]  D. Zaiss,et al.  Rates of Processing Determine the Immunogenicity of Immunoproteasome-Generated Epitopes1 , 2007, The Journal of Immunology.

[212]  T. Reinheckel,et al.  Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress , 1995, The Journal of Biological Chemistry.

[213]  Rieko Setsuie,et al.  The functions of UCH-L1 and its relation to neurodegenerative diseases , 2007, Neurochemistry International.

[214]  G. Paolisso,et al.  The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes , 2007, Cardiovascular diabetology.

[215]  S. W. Lin,et al.  Protein damage and degradation by oxygen radicals. II. Modification of amino acids. , 1987, The Journal of biological chemistry.

[216]  David H. Cribbs,et al.  Aβ Immunotherapy Leads to Clearance of Early, but Not Late, Hyperphosphorylated Tau Aggregates via the Proteasome , 2004, Neuron.

[217]  K. Rock,et al.  Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[218]  Liang Ge,et al.  Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. , 2007, Cell metabolism.

[219]  Robert M Friedlander,et al.  Apoptosis and caspases in neurodegenerative diseases. , 2003, The New England journal of medicine.

[220]  C. McLendon,et al.  Cerebrovascular endothelial dysfunction mediated by β‐amyloid , 1997 .

[221]  S. Waldman,et al.  Guanylyl cyclases and signaling by cyclic GMP. , 2000, Pharmacological reviews.

[222]  I. Wada,et al.  EDEM3, a Soluble EDEM Homolog, Enhances Glycoprotein Endoplasmic Reticulum-associated Degradation and Mannose Trimming* , 2006, Journal of Biological Chemistry.

[223]  R. Singh,et al.  UBE1L2, a Novel E1 Enzyme Specific for Ubiquitin*♦ , 2007, Journal of Biological Chemistry.

[224]  B. Ames,et al.  Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. , 2002, Neurotoxicology.

[225]  Nongluk Plongthongkum,et al.  Ire1 regulated XBP1 mRNA splicing is essential for the unfolded protein response (UPR) in Drosophila melanogaster. , 2007, Biochemical and biophysical research communications.

[226]  T. Reinheckel,et al.  Proteasome-dependent turnover of protein disulfide isomerase in oxidatively stressed cells. , 2002, Archives of biochemistry and biophysics.

[227]  M. Figueiredo-Pereira,et al.  A New Inhibitor of the Chymotrypsin‐Like Activity of the Multicatalytic Proteinase Complex (20S Proteasome) Induces Accumulation of Ubiquitin‐Protein Conjugates in a Neuronal Cell , 1994, Journal of neurochemistry.

[228]  J. Harris The isolation and purification of a macromolecular protein component from the human erythrocyte ghost. , 1969, Biochimica et biophysica acta.

[229]  A. Rivett,et al.  Phosphorylation of 20S proteasome alpha subunit C8 (alpha7) stabilizes the 26S proteasome and plays a role in the regulation of proteasome complexes by gamma-interferon. , 2004, The Biochemical journal.

[230]  Geoffrey P Lewis,et al.  Drusen-associated degeneration in the retina. , 2003, Investigative ophthalmology & visual science.

[231]  F. R. Papa,et al.  The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene , 1993, Nature.

[232]  S. Seregard,et al.  Age-related maculopathy: pathogenetic features and new treatment modalities. , 2002, Acta ophthalmologica Scandinavica.

[233]  A. Parant,et al.  Cystic fibrosis mortality trends in France. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[234]  Elke Krüger,et al.  Interferon‐γ, the functional plasticity of the ubiquitin–proteasome system, and MHC class I antigen processing , 2005, Immunological reviews.

[235]  A. Ciechanover,et al.  Oxidative stress‐related increase in ubiquitination in early coronary atherogenesis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[236]  M. Oren,et al.  Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[237]  T. Johnson,et al.  Proteasomal dysfunction activates the transcription factor SKN-1 and produces a selective oxidative-stress response in Caenorhabditis elegans. , 2008, The Biochemical journal.

[238]  A. Hauschild,et al.  Molecularly targeted therapy for melanoma , 2006, Cancer.

[239]  Tony Hunter,et al.  The regulation of transcription by phosphorylation , 1992, Cell.

[240]  A. Gimson,et al.  Cystic Fibrosis Liver Disease: To Transplant or Not to Transplant? , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[241]  P. Richardson,et al.  Novel therapies targeting the myeloma cell and its bone marrow microenvironment. , 2001, Seminars in oncology.

[242]  T. N. Palmer,et al.  Effect of acute and chronic alcohol treatment and their superimposition on lysosomal, cytoplasmic, and proteosomal protease activities in rat skeletal muscle in vivo. , 2002, Metabolism: clinical and experimental.

[243]  E. Rodriguez-Boulan,et al.  The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells , 2007, Proceedings of the National Academy of Sciences.

[244]  A. Bush,et al.  Metals and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[245]  G. Sobue,et al.  17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. , 2009, Human molecular genetics.

[246]  A. Emili,et al.  β‐Subunit appendages promote 20S proteasome assembly by overcoming an Ump1‐dependent checkpoint , 2007, The EMBO journal.

[247]  D. Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986. 46: 705-716. , 2006, Journal of immunology.

[248]  A. Rivett,et al.  Regulation of proteasome complexes by γ-interferon and phosphorylation , 2001 .

[249]  S. W. Lin,et al.  Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. , 1987, The Journal of biological chemistry.

[250]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[251]  Jeffrey N Keller,et al.  Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover* , 2004, Journal of Biological Chemistry.

[252]  U. Rüb,et al.  Spinocerebellar ataxia 2 (SCA2) , 2008, The Cerebellum.

[253]  T. Sommer,et al.  The Hrd1p ligase complex forms a linchpin between ER‐lumenal substrate selection and Cdc48p recruitment , 2006, The EMBO journal.

[254]  P. Coffino,et al.  Antizyme, a mediator of ubiquitin-independent proteasomal degradation. , 2001, Biochimie.

[255]  A. Richmond,et al.  Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells , 1997 .

[256]  Wendy Bruening,et al.  Up‐Regulation of Protein Chaperones Preserves Viability of Cells Expressing Toxic Cu/Zn‐Superoxide Dismutase Mutants Associated with Amyotrophic Lateral Sclerosis , 1999, Journal of neurochemistry.

[257]  J. Fallon,et al.  Up-regulation of the proteasome subunit LMP7 in tissues of endotoxemic rats. , 2000, The Journal of laboratory and clinical medicine.

[258]  J. Blumberg,et al.  Redox regulation of ubiquitin‐conjugating enzymes: mechanistic insights using the thiol‐specific oxidant diamide , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[259]  A. Goldberg,et al.  Patterns of gene expression in atrophying skeletal muscles: response to food deprivation , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[260]  Y. Jun,et al.  Human Cytomegalovirus UL18 Utilizes US6 for Evading the NK and T-Cell Responses , 2008, PLoS pathogens.

[261]  F. Tortella,et al.  Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. , 2000, Stroke.

[262]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[263]  F. Momburg,et al.  Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57 , 2006, Nature Immunology.

[264]  N. Breusing,et al.  Regulation of proteasome-mediated protein degradation during oxidative stress and aging , 2008, Biological chemistry.

[265]  R. Klausner,et al.  The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells , 1999, Molecular and Cellular Biology.

[266]  B. Friguet,et al.  Inhibition of the multicatalytic proteinase (proteasome) by 4‐hydroxy‐2‐nonenal cross‐linked protein , 1997, FEBS letters.

[267]  G. Yancopoulos,et al.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.

[268]  B. Friguet,et al.  Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. , 1994, The Journal of biological chemistry.

[269]  P. Kloetzel,et al.  Modeling the MHC class I pathway by combining predictions of proteasomal cleavage,TAP transport and MHC class I binding , 2005, Cellular and Molecular Life Sciences CMLS.

[270]  G. Martinelli,et al.  Molecular therapy for multiple myeloma. , 2001, Haematologica.

[271]  C. Lovati,et al.  Spinocerebellar ataxia type 17 (SCA17): Oculomotor phenotype and clinical characterization of 15 Italian patients , 2007, Journal of Neurology.

[272]  M. Orłowski,et al.  Reactions of [14C]-3,4-dichloroisocoumarin with subunits of pituitary and spleen multicatalytic proteinase complexes (proteasomes). , 1997, Biochemistry.

[273]  R. Tanzi,et al.  Endoproteolytic Cleavage and Proteasomal Degradation of Presenilin 2 in Transfected Cells* , 1997, The Journal of Biological Chemistry.

[274]  A. Ashworth,et al.  Identification of the familial cylindromatosis tumour-suppressor gene , 2000, Nature Genetics.

[275]  J. Miller,et al.  Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. , 1998, Alcoholism, clinical and experimental research.

[276]  O. Stemmann,et al.  The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts , 2007, Journal of Cell Science.

[277]  P. Kloetzel,et al.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[278]  H. Ploegh,et al.  Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. , 2006, Structure.

[279]  E. Kabashi,et al.  Failure of protein quality control in amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[280]  K. Nakayama,et al.  SCFβTrCP1 Activates and Ubiquitylates TAp63γ* , 2008, Journal of Biological Chemistry.

[281]  Bernd Bukau,et al.  The N-end rule pathway for regulated proteolysis: prokaryotic and eukaryotic strategies. , 2007, Trends in cell biology.

[282]  G. Sobue,et al.  Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1 , 2002, Brain Research.

[283]  R. Marfella,et al.  Possible dual role of ubiquitin-proteasome system in the atherosclerotic plaque progression. , 2008, Journal of the American College of Cardiology.

[284]  M. Bevan The Cutting Edge of T Cell Selection , 2007, Science.

[285]  R. Dean,et al.  Biochemistry and pathology of radical-mediated protein oxidation. , 1997, The Biochemical journal.

[286]  J. West-Mays,et al.  Differential regulation of components of the ubiquitin-proteasome pathway during lens cell differentiation. , 2004, Investigative ophthalmology & visual science.

[287]  Denham Harman,et al.  The Biologic Clock: The Mitochondria? , 1972, Journal of the American Geriatrics Society.

[288]  S. Lovestone,et al.  Neurofibrillary tangles and tau phosphorylation. , 2001, Biochemical Society symposium.

[289]  Peter T Lansbury,et al.  Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line. , 2003, Chemistry & biology.

[290]  A. Cuervo,et al.  A2E, a pigment of RPE lipofuscin, is generated from the precursor, A2PE by a lysosomal enzyme activity. , 2008, Advances in experimental medicine and biology.

[291]  J. Fischer,et al.  Effect of the glucocorticoid receptor antagonist RU 38486 on muscle protein breakdown in sepsis. , 1991, Surgery.

[292]  M. Tomonaga,et al.  Lactacystin activates FLICE (caspase 8) protease and induces apoptosis in Fas‐ resistant adult T‐cell leukemia cell lines , 2000, European journal of haematology.

[293]  B. Evers,et al.  The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies , 1999 .

[294]  T. Grune,et al.  Proteolysis, caloric restriction and aging , 2001, Mechanisms of Ageing and Development.

[295]  James Lowe,et al.  Depletion of 26S Proteasomes in Mouse Brain Neurons Causes Neurodegeneration and Lewy-Like Inclusions Resembling Human Pale Bodies , 2008, The Journal of Neuroscience.

[296]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[297]  P. Cresswell,et al.  MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding , 1994, Nature.

[298]  H. Yokosawa,et al.  Degradation of transcription factor IRF-1 by the ubiquitin-proteasome pathway. The C-terminal region governs the protein stability. , 2000, European journal of biochemistry.

[299]  K. Tanaka,et al.  A novel DNA vaccine based on ubiquitin–proteasome pathway targeting ‘self’-antigens expressed in melanoma/melanocyte , 2005, Gene Therapy.

[300]  M. Mattson Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.

[301]  M. Aridor Visiting the ER: the endoplasmic reticulum as a target for therapeutics in traffic related diseases. , 2007, Advanced drug delivery reviews.

[302]  P. Freemont,et al.  The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.

[303]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[304]  W. Dietrich,et al.  Inflammatory Mechanisms after Ischemia and Stroke , 2003, Journal of neuropathology and experimental neurology.

[305]  D. Pearce,et al.  The neuronal ceroid lipofuscinoses , 2007, NeuroMolecular Medicine.

[306]  J. Lucas,et al.  Full Motor Recovery Despite Striatal Neuron Loss and Formation of Irreversible Amyloid-Like Inclusions in a Conditional Mouse Model of Huntington's Disease , 2005, The Journal of Neuroscience.

[307]  A. Goldberg,et al.  The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes , 1999, The Journal of Biological Chemistry.

[308]  J. Han,et al.  The melanoma growth stimulatory activity receptor consists of two proteins. Ligand binding results in enhanced tyrosine phosphorylation. , 1992, Journal of immunology.

[309]  L. D. De Girolamo,et al.  Assessment of the direct and indirect effects of MPP+ and dopamine on the human proteasome: implications for Parkinson’s disease aetiology , 2008, Journal of neurochemistry.

[310]  C. Rupar,et al.  Rat liver lysosome membranes are enriched in alpha-tocopherol. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[311]  A. Wandinger-Ness,et al.  Functional analyses and interaction of the XAPC7 proteasome subunit with Rab7. , 2005, Methods in enzymology.

[312]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[313]  D. Rubinsztein,et al.  Ubiquitin ligase Hrd1 enhances the degradation and suppresses the toxicity of polyglutamine-expanded huntingtin. , 2007, Experimental cell research.

[314]  Kenneth C Anderson,et al.  Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions. , 2007, Experimental hematology.

[315]  D. Turk,et al.  Lysosomal cysteine proteases (cathepsins): promising drug targets. , 2003, Acta crystallographica. Section D, Biological crystallography.

[316]  R. Klausner,et al.  Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. , 1996, Biochimica et biophysica acta.

[317]  R. Wadhwa,et al.  Preincubation with the Proteasome Inhibitor MG‐132 Enhances Proteasome Activity via the Nrf2 Transcription Factor in Aging Human Skin Fibroblasts , 2006, Annals of the New York Academy of Sciences.

[318]  T. Reinheckel,et al.  Degradation of Oxidized Proteins in K562 Human Hematopoietic Cells by Proteasome* , 1996, The Journal of Biological Chemistry.

[319]  P. Elliott,et al.  Proteasome inhibition: a new anti-inflammatory strategy , 2003, Journal of Molecular Medicine.

[320]  Y. Wan,et al.  Mallory bodies formed in proteasome-depleted hepatocytes: an immunohistochemical study. , 2001, Experimental and molecular pathology.

[321]  P. Howley,et al.  DNA-repair protein hHR23a alters its protein structure upon binding proteasomal subunit S5a , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[322]  R. Plemper,et al.  Endoplasmic reticulum degradation. Reverse protein transport and its end in the proteasome , 1999, Molecular Biology Reports.

[323]  J. Harney,et al.  Ubc6p and ubc7p are required for normal and substrate-induced endoplasmic reticulum-associated degradation of the human selenoprotein type 2 iodothyronine monodeiodinase. , 2002, Molecular endocrinology.

[324]  S. Carillo,et al.  High plasma proteasome levels are detected in patients with metastatic malignant melanoma , 2005, The British journal of dermatology.

[325]  J. Lucas,et al.  The Ubiquitin-Proteasome System in Huntington’s Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[326]  J. Brodsky,et al.  ER protein quality control and proteasome-mediated protein degradation. , 1999, Seminars in cell & developmental biology.

[327]  V. Couch,et al.  von Hippel-Lindau disease. , 2000, Mayo Clinic proceedings.

[328]  J. Hirrlinger,et al.  Glutathione metabolism in brain , 2000 .

[329]  Richard G. Brusch,et al.  Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.

[330]  D. Rubinsztein,et al.  Decreased cAMP Response Element-mediated Transcription , 2004, Journal of Biological Chemistry.

[331]  B. Friguet,et al.  Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. , 1996, Archives of biochemistry and biophysics.

[332]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[333]  T. Saruta,et al.  Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells , 1995, FEBS letters.

[334]  J. Girault,et al.  Phosphorylation of Arfaptin 2 at Ser260 by Akt Inhibits PolyQ-huntingtin-induced Toxicity by Rescuing Proteasome Impairment* , 2005, Journal of Biological Chemistry.

[335]  Sunny Shin,et al.  Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. , 1998, Chemistry & biology.

[336]  T. Mizushima,et al.  The structure of the mammalian 20S proteasome at 2.75 A resolution. , 2002, Structure.

[337]  F. Tortella,et al.  Delayed Treatment with MLN519 Reduces Infarction and Associated Neurologic Deficit Caused by Focal Ischemic Brain Injury in Rats via Antiinflammatory Mechanisms Involving Nuclear Factor-κB Activation, Gliosis, and Leukocyte Infiltration , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[338]  Y. Takasaki,et al.  Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus , 1990, Clinical and experimental immunology.

[339]  M. Yáñez-Mó,et al.  von Hippel-Lindau tumor suppressor protein regulates the assembly of intercellular junctions in renal cancer cells through hypoxia-inducible factor-independent mechanisms. , 2006, Cancer research.

[340]  A. Rivett,et al.  Processing of N3, a mammalian proteasome beta-type subunit. , 1996, The Biochemical journal.

[341]  Brian Kuhlman,et al.  E2 conjugating enzymes must disengage from their E1 enzymes before E3-dependent ubiquitin and ubiquitin-like transfer , 2005, Nature Structural &Molecular Biology.

[342]  Boris Pfander,et al.  RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO , 2002, Nature.

[343]  G. Giebisch,et al.  CFTR is required for PKA-regulated ATP sensitivity of Kir1.1 potassium channels in mouse kidney. , 2006, The Journal of clinical investigation.

[344]  J. Tobias,et al.  Universality and structure of the N-end rule. , 1989, The Journal of biological chemistry.

[345]  L. Tessitore,et al.  Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. , 1996, Biochemical and biophysical research communications.

[346]  T. Zglinicki,et al.  Lipofuscin accumulation in proliferating fibroblasts in vitro: an indicator of oxidative stress , 2001, Experimental Gerontology.

[347]  K. Davies,et al.  Selective degradation of oxidatively modified protein substrates by the proteasome. , 2003, Biochemical and biophysical research communications.

[348]  Y. Kong,et al.  E2-25K/Hip-2 regulates caspase-12 in ER stress–mediated Aβ neurotoxicity , 2008, The Journal of cell biology.

[349]  B. Friguet,et al.  Proteasome and Photoaging , 2007, Annals of the New York Academy of Sciences.

[350]  J. Hanke Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreas , 2000, Anatomy and Embryology.

[351]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[352]  M. Goedert,et al.  Phosphorylation of tau by cyclic-AMP-dependent protein kinase. , 1993, Dementia.

[353]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[354]  Dawn C. Bisi,et al.  Sequential binding of UV DNA damage binding factor and degradation of the p48 subunit as early events after UV irradiation. , 2002, Nucleic acids research.

[355]  P. Thomas,et al.  Endoproteolytic Activity of the Proteasome , 2002, Science.

[356]  S. Wing,et al.  14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. , 1994, The American journal of physiology.

[357]  C. Crews,et al.  Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. , 2008, Chemistry & biology.

[358]  A. Goldberg,et al.  Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. , 1997, The Journal of clinical investigation.

[359]  R. Takahashi,et al.  Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis , 2002, Journal of neurochemistry.

[360]  A. Goette,et al.  Prevalence and pathology of amyloid in atherosclerotic arteries. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[361]  N. Hattori,et al.  Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin‐like domain , 2003, EMBO reports.

[362]  N. Agell,et al.  Different cytokines modulate ubiquitin gene expression in rat skeletal muscle. , 1998, Cancer letters.

[363]  P. Flakoll,et al.  Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. , 2002, American journal of physiology. Endocrinology and metabolism.

[364]  W. Baumeister,et al.  AAA-ATPases at the crossroads of protein life and death , 1999, Nature Cell Biology.

[365]  D. Haines,et al.  WW domains 2 and 3 of Rsp5p play overlapping roles in binding to the LPKY motif of Spt23p and Mga2p. , 2008, The international journal of biochemistry & cell biology.

[366]  Feras Hatahet,et al.  Substrate recognition by the protein disulfide isomerases , 2007, The FEBS journal.

[367]  J. Nowak,et al.  Age-related macular degeneration (AMD): pathogenesis and therapy. , 2006, Pharmacological reports : PR.

[368]  C. Crews,et al.  Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α', β'-epoxyketones , 1999 .

[369]  G. Sobue [Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)]. , 2003, Rinsho shinkeigaku = Clinical neurology.

[370]  M. Glickman,et al.  Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion. , 2008, Molecular biology of the cell.

[371]  Y. Ishii,et al.  Redox Regulation of Cell Growth and Cell Death , 2003, Biological chemistry.

[372]  A Ciechanover,et al.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[373]  R. Marfella,et al.  Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. , 1997, Circulation.

[374]  T. Pandita,et al.  Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability , 2008, Proceedings of the National Academy of Sciences.

[375]  Robert B. Petersen,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[376]  S. Lowe,et al.  Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. , 2005, Cancer research.

[377]  R. Schekman,et al.  Sec61p and BiP directly facilitate polypeptide translocation into the ER , 1992, Cell.

[378]  Tobias Jung,et al.  Age-related differences in oxidative protein-damage in young and senescent fibroblasts. , 2009, Archives of biochemistry and biophysics.

[379]  D. Ferrington,et al.  Altered proteasome structure, function, and oxidation in aged muscle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[380]  J. Weiss,et al.  Intrathecal infusion of a Ca2+-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS , 2007, Experimental Neurology.

[381]  A. Amerik,et al.  Mechanism and function of deubiquitinating enzymes. , 2004, Biochimica et biophysica acta.

[382]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[383]  A P Arrigo,et al.  Gene expression and the thiol redox state. , 1999, Free radical biology & medicine.

[384]  H. Schindelin,et al.  The sulfurtransferase activity of Uba4 presents a link between ubiquitin-like protein conjugation and activation of sulfur carrier proteins. , 2008, Biochemistry.

[385]  D. Busch,et al.  Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[386]  E. Stadtman Protein oxidation and aging , 2006, Science.

[387]  H. Brody The deposition of aging pigment in the human cerebral cortex. , 1960, Journal of gerontology.

[388]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[389]  Yulian Wu,et al.  The proteasome controls the expression of a proliferation‐associated nuclear antigen Ki‐67 , 2000, Journal of cellular biochemistry.

[390]  E. Stadtman,et al.  Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[391]  Yong Zhang,et al.  SPD—a web-based secreted protein database , 2004, Nucleic Acids Res..

[392]  D. Butterfield,et al.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.

[393]  E. Stadtman,et al.  Carbonyl assays for determination of oxidatively modified proteins. , 1994, Methods in enzymology.

[394]  E. Mandelkow,et al.  Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease , 2007, Brain pathology.

[395]  D.Y. Lee,et al.  Tob is a potential marker gene for the basal layer of the epidermis and is stably expressed in human primary keratinocytes , 2006, The British journal of dermatology.

[396]  Wei Guo,et al.  Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors , 2005, Oncogene.

[397]  Khadija Iqbal,et al.  Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. , 1998, Archives of biochemistry and biophysics.

[398]  N. Gonatas,et al.  Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1G93A mutation of familial amyotrophic lateral sclerosis , 2000, Journal of the Neurological Sciences.

[399]  J. Stankova,et al.  Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor* , 2003, Journal of Biological Chemistry.

[400]  J. Lee,et al.  Evidence That CD147 Modulation of β-Amyloid (Aβ) Levels Is Mediated by Extracellular Degradation of Secreted Aβ*♦ , 2008, Journal of Biological Chemistry.

[401]  Jie Liang,et al.  Subunit–subunit interactions in the human 26S proteasome , 2008, Proteomics.

[402]  J. Ávila Tau protein, the main component of paired helical filaments. , 2006, Journal of Alzheimer's disease : JAD.

[403]  R. Ferrante,et al.  Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[404]  D. Phoenix,et al.  Calpains: enzymes of vision? , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[405]  R. Dohmen,et al.  The C-terminal Extension of the β7 Subunit and Activator Complexes Stabilize Nascent 20 S Proteasomes and Promote Their Maturation* , 2007, Journal of Biological Chemistry.

[406]  S. Gerstberger,et al.  Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.

[407]  D. Ferrington,et al.  Altered proteasome function and subunit composition in aged muscle. , 2004, Archives of biochemistry and biophysics.

[408]  T. Iftner,et al.  Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/activator protein-1 signaling pathway. , 2005, Cancer research.

[409]  P. Lipton,et al.  Ischemic cell death in brain neurons. , 1999, Physiological reviews.

[410]  T. Maniatis,et al.  Generation of p50 subunit of NF-kB by processing of p105 through an ATP-dependent pathway , 1991, Nature.

[411]  K. Nakayama,et al.  CHIP promotes proteasomal degradation of familial ALS‐linked mutant SOD1 by ubiquitinating Hsp/Hsc70 , 2004, Journal of neurochemistry.

[412]  Ryoichi Arai,et al.  Structure of human ubiquitin-conjugating enzyme E2 G2 (UBE2G2/UBC7). , 2006, Acta crystallographica. Section F, Structural biology and crystallization communications.

[413]  K. Gould,et al.  Structural insights into the U-box, a domain associated with multi-ubiquitination , 2003, Nature Structural Biology.

[414]  Antonio Colombo,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. , 2003, Circulation.

[415]  H. Heinsen,et al.  Cortical and striatal neurone number in Huntington's disease , 2004, Acta Neuropathologica.

[416]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[417]  Weimin Guo,et al.  Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle. , 2004, Experimental eye research.

[418]  Ari Helenius,et al.  Quality control in the endoplasmic reticulum , 2003, Nature Reviews Molecular Cell Biology.

[419]  K. Davies,et al.  Importance of the Lon Protease in Mitochondrial Maintenance and the Significance of Declining Lon in Aging , 2007, Annals of the New York Academy of Sciences.

[420]  R. Plemper,et al.  Der3p/Hrd1p is required for endoplasmic reticulum-associated degradation of misfolded lumenal and integral membrane proteins. , 1998, Molecular biology of the cell.

[421]  Seung-Jae Lee α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease? , 2003 .

[422]  G. Blobel,et al.  The ubiquitin‐like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer , 1997, The EMBO journal.

[423]  G. Mills,et al.  Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-κB signaling , 2002, Oncogene.

[424]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[425]  J. Lucas,et al.  Is the ubiquitin-proteasome system impaired in Huntington’s disease? , 2007, Cellular and Molecular Life Sciences.

[426]  V. Marchesi,et al.  A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[427]  M. Molinari,et al.  EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation. , 2006, Biochemical and biophysical research communications.

[428]  A. Goldberg,et al.  26S proteasomes and immunoproteasomes produce mainly N‐extended versions of an antigenic peptide , 2001, The EMBO journal.

[429]  J. Rommens,et al.  Human Homologs of Ubc6p Ubiquitin-conjugating Enzyme and Phosphorylation of HsUbc6e in Response to Endoplasmic Reticulum Stress* , 2006, Journal of Biological Chemistry.

[430]  Lei Guo,et al.  Calreticulin in cardiac development and pathology. , 2002, Biochimica et biophysica acta.

[431]  C. Masters,et al.  The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth , 1992, Neuron.

[432]  F. Urano,et al.  Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity , 2007, Neurobiology of Disease.

[433]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[434]  Hans-Georg Rammensee,et al.  Coordinated Dual Cleavages Induced by the Proteasome Regulator PA28 Lead to Dominant MHC Ligands , 1996, Cell.

[435]  S. Alberti,et al.  The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator. , 2004, Molecular biology of the cell.

[436]  K. Chung,et al.  CREB activates proteasomal degradation of DSCR1/RCAN1 , 2008, FEBS letters.

[437]  N. Minato,et al.  The von Hippel-Lindau Tumor Suppressor Protein Mediates Ubiquitination of Activated Atypical Protein Kinase C* , 2001, The Journal of Biological Chemistry.

[438]  J. Kuszak,et al.  The ultrastructure of epithelial and fiber cells in the crystalline lens. , 1995, International review of cytology.

[439]  M. Orłowski,et al.  Evidence that Pituitary Cation‐Sensitive Neutral Endopeptidase Is a Multicatalytic Protease Complex , 1983, Journal of neurochemistry.

[440]  D. Ferrington,et al.  Catalytic site‐specific inhibition of the 20S proteasome by 4‐hydroxynonenal , 2004, FEBS letters.

[441]  R. Meyn,et al.  Protease inhibitors restore radiation‐induced apoptosis to Bcl‐2‐expressing lymphoma cells , 2001, International journal of cancer.

[442]  P. Cresswell,et al.  Proteasomes and Proteasome Activator 200 kDa (PA200) Accumulate on Chromatin in Response to Ionizing Radiation , 2007, Radiation research.

[443]  Matthew R. Johnson,et al.  Role of the β1 Subunit in the Function and Stability of the 20S Proteasome in the Hyperthermophilic Archaeon Pyrococcus furiosus , 2006 .

[444]  Weimin Guo,et al.  Ubiquitin-proteasome pathway function is required for lens cell proliferation and differentiation. , 2006, Investigative ophthalmology & visual science.

[445]  A. Goldberg,et al.  Oxygen radicals stimulate intracellular proteolysis and lipid peroxidation by independent mechanisms in erythrocytes. , 1987, The Journal of biological chemistry.

[446]  Christian Appenzeller‐Herzog,et al.  The human PDI family: versatility packed into a single fold. , 2008, Biochimica et biophysica acta.

[447]  J. Agar,et al.  Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis , 2004, Journal of neurochemistry.

[448]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[449]  M. Chesselet,et al.  Apoptosis in Huntington's disease , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[450]  David Baltimore,et al.  Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.

[451]  J. Tobias,et al.  The N-end rule in bacteria. , 1991, Science.

[452]  G. Burmester,et al.  Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). , 2008, Rheumatology.

[453]  M. Norman,et al.  Differential roles of ICAM‐1 and VCAM‐1 in leukocyte‐endothelial cell interactions in skin and brain of MRL/faslpr mice , 2008, Journal of leukocyte biology.

[454]  P. Burcham,et al.  Diminished susceptibility to proteolysis after protein modification by the lipid peroxidation product malondialdehyde: inhibitory role for crosslinked and noncrosslinked adducted proteins. , 1997, Archives of biochemistry and biophysics.

[455]  Raphaël Guérois,et al.  20S proteasome assembly is orchestrated by two distinct pairs of chaperones in yeast and in mammals. , 2007, Molecular cell.

[456]  D. Westaway,et al.  TMP21 is a presenilin complex component that modulates γ-secretase but not ɛ-secretase activity , 2006, Nature.

[457]  R. Mot Actinomycete-like proteasomes in a Gram-negative bacterium. , 2007 .

[458]  A. Badros,et al.  Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait. , 2005, Clinical advances in hematology & oncology : H&O.

[459]  T. Grune,et al.  Proteolysis of oxidised proteins and cellular senescence , 2000, Experimental Gerontology.

[460]  K. Davies,et al.  Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: part II—aging of nondividing cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[461]  T. Shearer,et al.  Biochemical properties of lens-specific calpain Lp85. , 2006, Experimental eye research.

[462]  Hiderou Yoshida,et al.  A time-dependent phase shift in the mammalian unfolded protein response. , 2003, Developmental cell.

[463]  F. Beaugé,et al.  The effects of acetaldehyde in vitro on proteasome activities and its potential involvement after alcoholization of rats by inhalation of ethanol vapours. , 2005, Alcohol and alcoholism.

[464]  N. Shimizu,et al.  Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. , 1999, Human gene therapy.

[465]  D. Figlewicz,et al.  Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.

[466]  B. J. Van den Eynde,et al.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. , 2001, Current opinion in immunology.

[467]  C. Gregorio,et al.  Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.

[468]  H. Nothwang,et al.  Prosomes and their multicatalytic proteinase activity. , 1992, European journal of biochemistry.

[469]  K. Davies Degradation of oxidized proteins by the 20S proteasome. , 2001, Biochimie.

[470]  G. Reifenberger,et al.  Coexpression of transforming growth factor-alpha and épidermal growth factor receptor in capillary hemangioblastomas of the central nervous system. , 1995, The American journal of pathology.

[471]  D. Yin Studies on age pigments evolving into a new theory of biological aging. , 1995, Gerontology.

[472]  Paul J Thornalley,et al.  Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes , 2005, Diabetologia.

[473]  K. Tanaka,et al.  Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes. , 1998, The Biochemical journal.

[474]  Maurizio Molinari,et al.  EDEM Contributes to Maintenance of Protein Folding Efficiency and Secretory Capacity* , 2004, Journal of Biological Chemistry.

[475]  E. Sausville,et al.  Proteasome inhibitors: a novel class of potent and effective antitumor agents. , 1999, Cancer research.

[476]  Jakob W. Risch,et al.  Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen. , 2002, Molecular biology of the cell.

[477]  F. Shang,et al.  Lens fibers have a fully functional ubiquitin-proteasome pathway. , 2002, Experimental eye research.

[478]  P. Cresswell,et al.  Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. , 1998, Immunity.

[479]  P. Kloetzel,et al.  Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus , 1996, The Journal of experimental medicine.

[480]  Keiji Tanaka,et al.  Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscles from tumor-bearing rats , 1999, Molecular Biology Reports.

[481]  B. Rost,et al.  NMR and X-RAY structures of human E2-like ubiquitin-fold modifier conjugating enzyme 1 (UFC1) reveal structural and functional conservation in the metazoan UFM1-UBA5-UFC1 ubiquination pathway , 2009, Journal of Structural and Functional Genomics.

[482]  Claire-Anne Gutekunst,et al.  Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.

[483]  A. Varshavsky,et al.  The degradation signal in a short-lived protein , 1989, Cell.

[484]  M. Bogyo,et al.  Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[485]  C. Harding,et al.  Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. , 1995, Journal of immunology.

[486]  J. Grandis,et al.  Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells , 2008, Molecular Cancer Therapeutics.

[487]  K. Nakashima,et al.  Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation , 2000, Acta Neuropathologica.

[488]  W. McBride,et al.  Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. , 2000, International journal of radiation oncology, biology, physics.

[489]  R. Sundaram,et al.  Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. , 1996, Clinical science.

[490]  N. Chondrogianni,et al.  Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence , 2007, Experimental Gerontology.

[491]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[492]  P. Goloubinoff,et al.  Chaperones and proteases , 2007, Journal of Molecular Neuroscience.

[493]  Feng-Sheng Wang,et al.  Flashlamp pulsed‐dye laser suppressed TGF‐β1 expression and proliferation in cultured keloid fibroblasts is mediated by MAPK pathway , 2007, Lasers in surgery and medicine.

[494]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[495]  G. Sobue,et al.  CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. , 2007, Brain : a journal of neurology.

[496]  E. Stadtman,et al.  Methionine sulfoxide reductase in antioxidant defense. , 1999, Methods in enzymology.

[497]  Randal J. Kaufman,et al.  Divergent Roles of IRE1α and PERK in the Unfolded Protein Response , 2006 .

[498]  J. Arribas,et al.  Phosphorylation of C8 and C9 subunits of the multicatalytic proteinase by casein kinase II and identification of the C8 phosphorylation sites by direct mutagenesis. , 1996, Biochemistry.

[499]  K. Ndebele,et al.  17-β-ESTRADIOL SUPPRESSES IL-2 AND IL-2 RECEPTOR , 2001 .

[500]  A. Malovannaya,et al.  The SRC-3/AIB1 Coactivator Is Degraded in a Ubiquitin- and ATP-Independent Manner by the REGγ Proteasome , 2006, Cell.

[501]  A. Helenius,et al.  Multiple Endoplasmic Reticulum-associated Pathways Degrade Mutant Yeast Carboxypeptidase Y in Mammalian Cells* , 2003, Journal of Biological Chemistry.

[502]  J. Lieberman,et al.  Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. , 2001, Blood.

[503]  L. Papa,et al.  Persistent mitochondrial dysfunction and oxidative stress hinder neuronal cell recovery from reversible proteasome inhibition , 2008, Apoptosis.

[504]  Tom A. Rapoport,et al.  Distinct Ubiquitin-Ligase Complexes Define Convergent Pathways for the Degradation of ER Proteins , 2006, Cell.

[505]  Kees Jalink,et al.  Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. , 2003, Immunity.

[506]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[507]  M. Glucksman,et al.  Involvement of surface cysteines in activity and multimer formation of thimet oligopeptidase. , 2003, Protein engineering.

[508]  A. Brunger,et al.  Structure and function of the yeast U-box-containing ubiquitin ligase Ufd2p , 2007, Proceedings of the National Academy of Sciences.

[509]  C. Masters,et al.  Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein , 1999, Nature Structural Biology.

[510]  W. Mitch,et al.  Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process. , 2005, The international journal of biochemistry & cell biology.

[511]  J. Manfredi,et al.  Multiple roles of the tumor suppressor p53 , 2002, Current opinion in oncology.

[512]  A. Holmgren,et al.  The Contributions of Protein Disulfide Isomerase and Its Homologues to Oxidative Protein Folding in the Yeast Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[513]  U. Brunk,et al.  Lipofuscin: Mechanisms of formation and increase with age , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[514]  Claudia Leidhold,et al.  Chaperones and Proteases—Guardians of Protein Integrity in Eukaryotic Organelles , 2007, Annals of the New York Academy of Sciences.

[515]  P. Osmulski,et al.  Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity. , 2003, Biochemistry.

[516]  M. Vu,et al.  Proteasomes Modulate Balance Among Proapoptotic and Antiapoptotic Bcl-2 Family Members and Compromise Functioning of the Electron Transport Chain in Leukemic Cells1 , 2001, The Journal of Immunology.

[517]  P. Karplus,et al.  Protein sulfenic acids in redox signaling. , 2004, Annual review of pharmacology and toxicology.

[518]  D. Turk,et al.  Lysosomal cysteine proteases: facts and opportunities , 2001, The EMBO journal.

[519]  A. Holmgren,et al.  Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. , 2004, Antioxidants & redox signaling.

[520]  O. Niemelä,et al.  Early alcoholic liver injury: formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A. , 1998, Alcoholism, clinical and experimental research.

[521]  P. Fisher,et al.  Secretable chaperone Grp170 enhances therapeutic activity of a novel tumor suppressor, mda-7/IL-24. , 2008, Cancer research.

[522]  J. Sacchettini,et al.  Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[523]  C. Ji,et al.  UBE1DC1, an ubiquitin‐activating enzyme, activates two different ubiquitin‐like proteins , 2008, Journal of cellular biochemistry.

[524]  P. Zhou,et al.  Genomic organization and tissue expression of the mouse proteasome gene Lmp-7 , 1993, Immunogenetics.

[525]  J. Huibregtse,et al.  A Single PXY Motif Located within the Carboxyl Terminus of Spt23p and Mga2p Mediates a Physical and Functional Interaction with Ubiquitin Ligase Rsp5p* , 2004, Journal of Biological Chemistry.

[526]  A. Buchberger,et al.  UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97 , 2008, Cellular and Molecular Life Sciences.

[527]  P. Kloetzel,et al.  Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.

[528]  A. Cederbaum,et al.  Oxidative stress, toxicology, and pharmacology of CYP2E1. , 2004, Annual review of pharmacology and toxicology.

[529]  Nadinath B. Nillegoda,et al.  Ydj1 Protects Nascent Protein Kinases from Degradation and Controls the Rate of Their Maturation , 2008, Molecular and Cellular Biology.

[530]  Yuh-Shan Jou,et al.  A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. , 2006, Journal of the National Cancer Institute.

[531]  T. Grune,et al.  Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. , 2000, Archives of biochemistry and biophysics.

[532]  N. Osna,et al.  Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity. , 2006, The international journal of biochemistry & cell biology.

[533]  S. Rosenkranz,et al.  PI3‐kinase/Akt‐dependent antiapoptotic signaling by the PDGF α receptor is negatively regulated by Src family kinases , 2006, FEBS letters.

[534]  M. Kuroda,et al.  Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093. , 2000, The Journal of organic chemistry.

[535]  J. de Magalhães,et al.  Stress‐induced premature senescence in BJ and hTERT‐BJ1 human foreskin fibroblasts , 2002, FEBS letters.

[536]  F. Mach,et al.  Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes. , 2009, Rheumatology.

[537]  E. Feldman,et al.  Oxidative stress in the pathogenesis of diabetic neuropathy. , 2004, Endocrine reviews.

[538]  Pathogenesis of Diabetic Neuropathy , 1997 .

[539]  T. Kudo,et al.  Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil , 2008, Brain Research.

[540]  P. Chinnery,et al.  Pathogenic expansions of the SCA6 locus are associated with a common CACNA1A haplotype across the globe: founder effect or predisposing chromosome? , 2008, European Journal of Human Genetics.

[541]  P. Henklein,et al.  Expression and subcellular localization of mouse 20S proteasome activator complex PA28 , 1997, FEBS letters.

[542]  E. Stadtman,et al.  Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.

[543]  R. Morimoto,et al.  Structural properties and neuronal toxicity of amyotrophic lateral sclerosis–associated Cu/Zn superoxide dismutase 1 aggregates , 2005, The Journal of cell biology.

[544]  Amy S. Lee,et al.  ER chaperones in mammalian development and human diseases , 2007, FEBS letters.

[545]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[546]  J. Simon,et al.  Retinyl palmitate and the blue-light-induced phototoxicity of human ocular lipofuscin. , 2001, Archives of biochemistry and biophysics.

[547]  L. Dick,et al.  Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin , 1996, The Journal of Biological Chemistry.

[548]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[549]  K. Moremen,et al.  Energetics of Substrate Binding and Catalysis by Class 1 (Glycosylhydrolase Family 47) α-Mannosidases Involved in N-Glycan Processing and Endoplasmic Reticulum Quality Control*[boxs] , 2005, Journal of Biological Chemistry.

[550]  Yan Liu,et al.  Oligosaccharide Modification in the Early Secretory Pathway Directs the Selection of a Misfolded Glycoprotein for Degradation by the Proteasome* , 1999, The Journal of Biological Chemistry.

[551]  L. Klotz,et al.  Nitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress. , 2007, Free radical biology & medicine.

[552]  Beatriz Alvarez-Castelao,et al.  Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain , 2006, Journal of neurochemistry.

[553]  N. Chen,et al.  Overexpressed Alpha-Synuclein Regulated the Nuclear Factor-kappaB Signal Pathway , 2007, Cellular and Molecular Neurobiology.

[554]  O. Ullrich,et al.  Stability of the nuclear protein turnover during cellular senescence of human fibroblasts , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[555]  A. Goldberg,et al.  Proteins damaged by oxygen radicals are rapidly degraded in extracts of red blood cells. , 1987, The Journal of biological chemistry.

[556]  J. Stephens,et al.  Induction of SOCS-3 is insufficient to confer IRS-1 protein degradation in 3T3-L1 adipocytes. , 2006, Biochemical and biophysical research communications.

[557]  Yi Sun,et al.  Targeting E3 Ubiquitin Ligases for Cancer Therapy , 2003, Cancer biology & therapy.

[558]  W. Markesbery,et al.  Decreased levels of proteasome activity and proteasome expression in aging spinal cord , 2000, Neuroscience.

[559]  V. Bours,et al.  Spinocerebellar ataxia type 2 (SCA2): clinical features and genetic analysis. , 2008, Journal of tropical pediatrics.

[560]  J. Ávila,et al.  Tau Phosphorylation, Aggregation, and Cell Toxicity , 2006, Journal of biomedicine & biotechnology.

[561]  T. Bayer,et al.  Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[562]  M. Strong,et al.  The Pathobiology of Amyotrophic Lateral Sclerosis: A Proteinopathy? , 2005, Journal of neuropathology and experimental neurology.

[563]  R. Levine,et al.  Modulation of the hydrophobicity of glutamine synthetase by mixed‐function oxidation , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[564]  H. Pan,et al.  Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. , 1994, Genes & development.

[565]  M. Groll,et al.  Diversity of proteasomal missions: fine tuning of the immune response , 2007, Biological chemistry.

[566]  C. Slaughter,et al.  PA28, an activator of the 20 S proteasome, is inactivated by proteolytic modification at its carboxyl terminus. , 1993, The Journal of biological chemistry.

[567]  Zhijian J. Chen,et al.  Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin Chain , 2000, Cell.

[568]  T. Grune,et al.  Oxidation-induced ferritin turnover in microglial cells: role of proteasome. , 2005, Free radical biology & medicine.

[569]  Min Chen,et al.  Xenobiotic‐Induced Recruitment of Autoantigens to Nuclear Proteasomes Suggests a Role for Altered Antigen Processing in Scleroderma , 2005, Annals of the New York Academy of Sciences.

[570]  D. Hebert,et al.  EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites , 2007, Proceedings of the National Academy of Sciences.

[571]  J. Evans,et al.  Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis , 2008, Eye.

[572]  M. Hochstrasser,et al.  Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[573]  D. Green,et al.  Mechanisms of p53-dependent apoptosis. , 2001, Biochemical Society transactions.

[574]  Tilman Grune,et al.  Lipofuscin: formation, distribution, and metabolic consequences. , 2007, Annals of the New York Academy of Sciences.

[575]  W. Hung,et al.  Intense Superoxide Dismutase‐1 Immunoreactivity in Intracytoplasmic Hyaline Inclusions of Familial Amyotrophic Lateral Sclerosis with Posterior Column Involvement , 1996, Journal of neuropathology and experimental neurology.

[576]  P. Elliott,et al.  Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. , 2000, Journal of autoimmunity.

[577]  B. Oostra,et al.  The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair , 2006, Neurobiology of Disease.

[578]  K. Davies,et al.  Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. , 2006, The Biochemical journal.

[579]  M. Hochstrasser,et al.  Autocatalytic Subunit Processing Couples Active Site Formation in the 20S Proteasome to Completion of Assembly , 1996, Cell.

[580]  C. Olanow,et al.  Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.

[581]  M. Molinari,et al.  Segregation and rapid turnover of EDEM1 by an autophagy-like mechanism modulates standard ERAD and folding activities. , 2008, Biochemical and biophysical research communications.

[582]  U. Brunk,et al.  The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. , 2006, Chemico-biological interactions.

[583]  Alexei F. Kisselev,et al.  Processive Degradation of Proteins and Other Catalytic Properties of the Proteasome from Thermoplasma acidophilum* , 1997, The Journal of Biological Chemistry.

[584]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[585]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[586]  E. Bennett,et al.  Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. , 2005, Molecular cell.

[587]  K. Xia,et al.  TMP21 degradation is mediated by the ubiquitin‐proteasome pathway , 2008, The European journal of neuroscience.

[588]  R. Kayed,et al.  Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers. , 2006, The Journal of clinical investigation.

[589]  Yan-chen Xie,et al.  Trinucleotide expansions in the SCA7 gene in a large family with spinocerebellar ataxia and craniocervical dystonia , 2008, Neuroscience Letters.

[590]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[591]  Christopher A Ross,et al.  Polyglutamine Pathogenesis Emergence of Unifying Mechanisms for Huntington's Disease and Related Disorders , 2002, Neuron.

[592]  C. Reilly,et al.  Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. , 2007, Investigative ophthalmology & visual science.

[593]  C. Slaughter,et al.  Primary structures of two homologous subunits of PA28, a γ‐interferon‐inducible protein activator of the 20S proteasome , 1995, FEBS letters.

[594]  J. P. Jensen,et al.  Expression, purification, and properties of the Ubc4/5 family of E2 enzymes. , 2005, Methods in enzymology.

[595]  L. Mouthon,et al.  Physiopathologie de la sclérodermie systémique: état des lieux sur une affection aux multiples facettes , 2006 .

[596]  R. Binder,et al.  Heat Shock Protein-chaperoned Peptides but Not Free Peptides Introduced into the Cytosol Are Presented Efficiently by Major Histocompatibility Complex I Molecules* , 2001, The Journal of Biological Chemistry.

[597]  K. Matrougui,et al.  Mice lacking the gene encoding for MMP-9 and resistance artery reactivity. , 2006, Biochemical and biophysical research communications.

[598]  T. Reinheckel,et al.  Comparative resistance of the 20S and 26S proteasome to oxidative stress. , 1998, The Biochemical journal.

[599]  P. Kloetzel,et al.  The proteasome and MHC class I antigen processing. , 2004, Biochimica et biophysica acta.

[600]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[601]  R. Huber,et al.  Structure of 20S proteasome from yeast at 2.4Å resolution , 1997, Nature.

[602]  K. Davies,et al.  Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[603]  J. Yewdell,et al.  Immunoproteasomes: regulating the regulator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[604]  B. Friguet,et al.  Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. , 2006, Archives of biochemistry and biophysics.

[605]  B. Friguet,et al.  Oxidative Modification and Inactivation of the Proteasome during Coronary Occlusion/Reperfusion* , 2001, The Journal of Biological Chemistry.

[606]  B. Friguet,et al.  Age-dependent declines in proteasome activity in the heart. , 2002, Archives of biochemistry and biophysics.

[607]  S. Demo,et al.  Drug discovery in the ubiquitin regulatory pathway. , 2003, Drug discovery today.

[608]  S. W. Lin,et al.  Degradation of oxidatively denatured proteins in Escherichia coli. , 1988, Free radical biology & medicine.

[609]  C. Crews,et al.  The ubiquitin‐proteasome pathway and proteasome inhibitors , 2001, Medicinal research reviews.

[610]  A. Grover,et al.  Hyperphosphorylation-induced self assembly of murine tau: a comparison with human tau , 2005, Journal of Neural Transmission.

[611]  J. Arribas,et al.  Proteolytic Processing and Assembly of the C5 Subunit into the Proteasome Complex* , 2000, The Journal of Biological Chemistry.

[612]  E. Wiertz,et al.  Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. , 2006, International immunology.

[613]  T. Hoppe,et al.  Multiubiquitylation by E4 enzymes: 'one size' doesn't fit all. , 2005, Trends in biochemical sciences.

[614]  Z Chen,et al.  Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[615]  E. Porta Pigments in Aging: An Overview , 2002, Annals of the New York Academy of Sciences.

[616]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[617]  M. Moskowitz,et al.  Attenuated hippocampal damage after global cerebral ischemia in mice mutant in neuronal nitric oxide synthase , 1996, Neuroscience.

[618]  K. Kimura,et al.  Dysfunction of the ER chaperone BiP accelerates the renal tubular injury. , 2008, Biochemical and biophysical research communications.

[619]  G. Kroemer [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.

[620]  A. Mogk,et al.  Proteomic Analysis of Mitochondrial Protein Turnover: Identification of Novel Substrate Proteins of the Matrix Protease Pim1 , 2006, Molecular and Cellular Biology.

[621]  J. Stankova,et al.  Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor. , 2007, Cellular signalling.

[622]  M. Papotti,et al.  Interferon-γ-inducible subunits are incorporated in human brain 20S proteasome , 2003, Journal of Neuroimmunology.

[623]  C. Kretz-remy,et al.  Gene expression and thiol redox state. , 1999, Methods in enzymology.

[624]  Ulf Hellman,et al.  The Final N-Terminal Trimming of a Subaminoterminal Proline-Containing HLA Class I-Restricted Antigenic Peptide in the Cytosol Is Mediated by Two Peptidases1 , 2002, The Journal of Immunology.

[625]  D. Pain,et al.  Mrs3p, Mrs4p, and Frataxin Provide Iron for Fe-S Cluster Synthesis in Mitochondria* , 2006, Journal of Biological Chemistry.

[626]  G. Cortopassi,et al.  Frataxin, iron-sulfur clusters, heme, ROS, and aging. , 2006, Antioxidants & redox signaling.

[627]  C. Bartsch,et al.  Long‐term up‐regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin–proteasome pathway , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[628]  J. Blein,et al.  Proteasome comprising a β1 inducible subunit acts as a negative regulator of NADPH oxidase during elicitation of plant defense reactions , 2005, FEBS letters.

[629]  J. Newell,et al.  The RING finger protein Siah‐1 regulates the level of the transcriptional coactivator OBF‐1 , 2001, The EMBO journal.

[630]  M. Elleder,et al.  Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders , 1997, Acta Neuropathologica.

[631]  A. Goldberg,et al.  Selective Inhibitors of the Proteasome-dependent and Vacuolar Pathways of Protein Degradation in Saccharomyces cerevisiae * , 1996, The Journal of Biological Chemistry.

[632]  M. Salmona,et al.  Insoluble Mutant SOD1 Is Partly Oligoubiquitinated in Amyotrophic Lateral Sclerosis Mice* , 2006, Journal of Biological Chemistry.

[633]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[634]  J. Tschopp,et al.  NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.

[635]  P. Kloetzel,et al.  The Role of the Proteasome System and the Proteasome Activator PA28 Complex in the Cellular Immune Response , 1999, Biological chemistry.

[636]  R. Tampé,et al.  Structure and Dynamics of Membrane-associated ICP47, a Viral Inhibitor of the MHC I Antigen-processing Machinery* , 2006, Journal of Biological Chemistry.

[637]  M. Satoh,et al.  Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. , 1991, Cancer research.

[638]  G. Plant,et al.  Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.

[639]  K. Tanaka,et al.  Half-life of proteasomes (multiprotease complexes) in rat liver. , 1989, Biochemical and biophysical research communications.

[640]  P. Elliott,et al.  Proteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. , 2002, The Journal of clinical investigation.

[641]  J. Qin,et al.  Structure and interactions of the helical and U-box domains of CHIP, the C terminus of HSP70 interacting protein. , 2006, Biochemistry.

[642]  R. Sitia,et al.  Dynamic retention of Ero1α and Ero1β in the endoplasmic reticulum by interactions with PDI and ERp44 , 2006 .

[643]  Keiji Tanaka,et al.  The molecular chaperone Hsp90 plays a role in the assembly and maintenance of the 26S proteasome , 2003, The EMBO journal.

[644]  A. Ceriello Postprandial hyperglycemia and diabetes complications: is it time to treat? , 2005, Diabetes.

[645]  J. Neefjes,et al.  MHC class I alleles and their exploration of the antigen‐processing machinery , 2005, Immunological reviews.

[646]  V. Prieto,et al.  Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array , 2003, Journal of cutaneous pathology.

[647]  S. French,et al.  CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. , 2006, Experimental and molecular pathology.

[648]  K. Vandenbroeck,et al.  Protein disulfide isomerase-mediated cell-free assembly of recombinant interleukin-12 p40 homodimers. , 2000, European journal of biochemistry.

[649]  Christopher A. Ross,et al.  Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization* , 2002, The Journal of Biological Chemistry.

[650]  T. Casoli,et al.  Morphometry of age pigment (lipofuscin) and of ceroid pigment deposits associated with vitamin E deficiency. , 2002, Archives of gerontology and geriatrics.

[651]  C. Kahn,et al.  Frataxin promotes antioxidant defense in a thiol-dependent manner resulting in diminished malignant transformation in vitro. , 2002, Human molecular genetics.

[652]  M. Kawahara,et al.  Phosphorylation of tau at serine 416 by Ca2+/calmodulin‐dependent protein kinase II in neuronal soma in brain , 2005, Journal of neurochemistry.

[653]  Asif Ahmed,et al.  VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. , 2006, Biochemical and biophysical research communications.

[654]  M. P. Miano,et al.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.

[655]  A. Shuaib,et al.  Involvement of inflammatory cytokines in central nervous system injury , 2002, Progress in Neurobiology.

[656]  A Helenius,et al.  Setting the standards: quality control in the secretory pathway. , 1999, Science.

[657]  K. Tanaka,et al.  Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells. , 1992, The Journal of biological chemistry.

[658]  J. Schulz,et al.  Mitochondrial Protein Quality Control by the Proteasome Involves Ubiquitination and the Protease Omi* , 2008, Journal of Biological Chemistry.

[659]  A. Prescott,et al.  Gap junctions containing alpha8-connexin (MP70) in the adult mammalian lens epithelium suggests a re-evaluation of its role in the lens. , 1999, Experimental eye research.

[660]  F. López‐Soriano,et al.  Does the mechanism responsible for TNF-mediated insulin resistance involve the proteasome? , 2000, Medical hypotheses.

[661]  M. Youdim,et al.  Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. , 1994, Life sciences.

[662]  J. A. Thomas,et al.  S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. , 1999, Archives of biochemistry and biophysics.

[663]  P. Howell,et al.  Structural Basis for Catalysis and Inhibition ofN-Glycan Processing Class I α1,2-Mannosidases* , 2000, The Journal of Biological Chemistry.

[664]  T. Mizushima,et al.  New crystal forms and low resolution structure analysis of 20S proteasomes from bovine liver. , 2000, Journal of biochemistry.

[665]  A. Rivett,et al.  Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. , 1985, The Journal of biological chemistry.

[666]  D. Butterfield,et al.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.

[667]  S. Gygi,et al.  The HEAT repeat protein Blm10 regulates the yeast proteasome by capping the core particle , 2005, Nature Structural &Molecular Biology.

[668]  J. Peters,et al.  Proteasomes: protein degradation machines of the cell. , 1994, Trends in biochemical sciences.

[669]  J. Andersen,et al.  Does cellular iron dysregulation play a causative role in Parkinson’s disease? , 2004, Ageing Research Reviews.

[670]  R. Rubenstein Novel, mechanism-based therapies for cystic fibrosis , 2005, Current opinion in pediatrics.

[671]  M. Ingelman-Sundberg,et al.  Role of CYP2E1 in the pathogenesis of alcoholic liver disease: modifications by cAMP and ubiquitin-proteasome pathway. , 1999, Frontiers in bioscience : a journal and virtual library.

[672]  N. Chondrogianni,et al.  Overexpression of Proteasome β5 Assembled Subunit Increases the Amount of Proteasome and Confers Ameliorated Response to Oxidative Stress and Higher Survival Rates*[boxs] , 2005, Journal of Biological Chemistry.

[673]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[674]  D. Nowis,et al.  Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates. , 2006, Experimental cell research.

[675]  M. Glickman,et al.  Yeast Antizyme Mediates Degradation of Yeast Ornithine Decarboxylase by Yeast but Not by Mammalian Proteasome , 2008, Journal of Biological Chemistry.

[676]  C. Reilly,et al.  Transformation of the proteasome with age‐related macular degeneration , 2007, FEBS letters.

[677]  Keiji Tanaka,et al.  Proteasome activator (PA28) subunits, α, β and γ (Ki antigen) in NT2 neuronal precursor cells and HeLa S3 cells , 1998 .

[678]  T. Mizushima,et al.  Structure determination of the constitutive 20S proteasome from bovine liver at 2.75 A resolution. , 2002, Journal of biochemistry.

[679]  Bart Barlogie,et al.  A phase 2 study of bortezomib in relapsed, refractory myeloma. , 2003, The New England journal of medicine.

[680]  C. Warren Olanow,et al.  Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.

[681]  M. Orłowski,et al.  Catalytic activities of the 20 S proteasome, a multicatalytic proteinase complex. , 2000, Archives of biochemistry and biophysics.

[682]  Y. Kagawa,et al.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.

[683]  H. Ploegh,et al.  Mechanisms, biology and inhibitors of deubiquitinating enzymes. , 2007, Nature chemical biology.

[684]  A. Ciechanover,et al.  The ubiquitin-proteasome system in cardiovascular diseases-a hypothesis extended. , 2004, Cardiovascular research.

[685]  M. Nakanishi,et al.  A degradation signal located in the C‐terminus of p21WAF1/CIP1 is a binding site for the C8 α‐subunit of the 20S proteasome , 2001, The EMBO journal.

[686]  F. Menzies,et al.  Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress. , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[687]  Hans-Georg Rammensee,et al.  Two new proteases in the MHC class I processing pathway , 2000, Nature Immunology.

[688]  A. Holmgren,et al.  The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. , 1994, The Journal of biological chemistry.

[689]  J. Sosman,et al.  Molecular Targets in Melanoma from Angiogenesis to Apoptosis , 2006, Clinical Cancer Research.

[690]  T. McDonnell,et al.  Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53 , 1998, Oncogene.

[691]  C. Fan,et al.  Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator , 2006, Cell.

[692]  M. Tisdale,et al.  Mechanism of muscle protein degradation induced by a cancer cachectic factor. , 1998, British Journal of Cancer.

[693]  A. Tomkinson,et al.  The N-degron protein degradation strategy for investigating the function of essential genes: requirement for replication protein A and proliferating cell nuclear antigen proteins for nucleotide excision repair in yeast extracts. , 1998, Mutation research.

[694]  N. Munshi,et al.  Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. , 2002, Blood.

[695]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[696]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[697]  T. Nakamura,et al.  An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[698]  T. Kurz Can lipofuscin accumulation be prevented? , 2008, Rejuvenation research.

[699]  T. Elliott,et al.  Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport , 1995, European journal of immunology.

[700]  B. Friguet,et al.  Proteasome function in aging and oxidative stress: implications in protein maintenance failure. , 2006, Antioxidants & redox signaling.

[701]  A. Goldberg,et al.  The Internal Sequence of the Peptide-Substrate Determines Its N-Terminus Trimming by ERAP1 , 2008, PloS one.

[702]  U. Brunk,et al.  Testing the “garbage” accumulation theory of ageing: mitotic activity protects cells from death induced by inhibition of autophagy , 2004, Biogerontology.

[703]  M. McMahon,et al.  Oncogenic BRAFV600E inhibits BIM expression to promote melanoma cell survival , 2008, Pigment cell & melanoma research.

[704]  P. T. Englund,et al.  Identification of a Bacterial-Like HslVU Protease in the Mitochondria of Trypanosoma brucei and Its Role in Mitochondrial DNA Replication , 2008, PLoS pathogens.

[705]  Toshiharu Suzuki,et al.  Endoplasmic reticulum chaperones inhibit the production of amyloid-β peptides , 2007 .

[706]  J. Sjöstrand,et al.  Decreased caspase-3 activity in human lens epithelium from posterior subcapsular cataracts. , 2003, Experimental eye research.

[707]  E. Stadtman,et al.  Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[708]  F. Latif,et al.  Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. , 1995, Oncogene.

[709]  P. Kloetzel,et al.  Antitopes Define Preferential Proteasomal Cleavage Site Usage* , 2008, Journal of Biological Chemistry.

[710]  A. Goldberg,et al.  Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.

[711]  D. Rubinsztein,et al.  Transcriptional abnormalities in Huntington disease. , 2003, Trends in genetics : TIG.

[712]  D. Finley,et al.  A Ubiquitin Stress Response Induces Altered Proteasome Composition , 2007, Cell.

[713]  M. Portero-Otín,et al.  Diabetes induces an impairment in the proteolytic activity against oxidized proteins and a heterogeneous effect in nonenzymatic protein modifications in the cytosol of rat liver and kidney. , 1999, Diabetes.

[714]  B. Walker,et al.  Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals). , 1998, Bioorganic & medicinal chemistry letters.

[715]  B. Friguet,et al.  Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. , 2002, Free radical biology & medicine.

[716]  A. Goldberg,et al.  Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes , 2002, The EMBO journal.

[717]  A. Babour,et al.  Two Hrd1p homologues in the yeast Yarrowia lipolytica which act in different pathways , 2006, Molecular Genetics and Genomics.

[718]  T. Reinheckel,et al.  Degradation of oxidized proteins in mammalian cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[719]  J. Milbrandt,et al.  Ionizing Radiation Down-regulates p53 Protein in Primary Egr-1−/− Mouse Embryonic Fibroblast Cells Causing Enhanced Resistance to Apoptosis* , 2001, The Journal of Biological Chemistry.

[720]  S. Holland,et al.  Defects in the interferon‐γ and interleukin‐12 pathways , 2005, Immunological reviews.

[721]  Jianping Liu,et al.  Isolation and Characterization of Ubiquitin-activating Enzyme E1-domain Containing 1, UBE1DC1 , 2005, Molecular Biology Reports.

[722]  M. Hochstrasser SP-RING for SUMO New Functions Bloom for a Ubiquitin-like Protein , 2001, Cell.

[723]  J. Song,et al.  Chaperone-like activity of protein disulfide-isomerase in the refolding of rhodanese. , 1995, European journal of biochemistry.

[724]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[725]  A. Fukamizu,et al.  Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase. , 2008, International journal of molecular medicine.

[726]  M. Wride,et al.  Minireview: Apoptosis as seen through a lens , 2000, Apoptosis.

[727]  R. McCarron,et al.  Induction of Mucosal Tolerance to E-Selectin Prevents Ischemic and Hemorrhagic Stroke in Spontaneously Hypertensive Genetically Stroke-Prone Rats , 2002, Stroke.

[728]  F. Groenendaal,et al.  A Dual Role of the NF-&kgr;B Pathway in Neonatal Hypoxic-Ischemic Brain Damage , 2008, Stroke.

[729]  Marian Orlowski,et al.  Bovine Spleen Multicatalytic Proteinase Complex (Proteasome) , 1997, The Journal of Biological Chemistry.

[730]  S. Wagner,et al.  Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression , 2003, Melanoma research.

[731]  T. Grune,et al.  Protein oxidation and proteolysis in RAW264.7 macrophages: effects of PMA activation. , 2001, Biochimica et biophysica acta.

[732]  B. Schulman,et al.  Expression, purification, and characterization of the E1 for human NEDD8, the heterodimeric APPBP1-UBA3 complex. , 2005, Methods in enzymology.

[733]  D. Wolf,et al.  Ubiquitin receptors and ERAD: a network of pathways to the proteasome. , 2007, Seminars in cell & developmental biology.

[734]  Jack Iwanczyk,et al.  Structure of the Blm10-20 S proteasome complex by cryo-electron microscopy. Insights into the mechanism of activation of mature yeast proteasomes. , 2006, Journal of molecular biology.

[735]  R. Youle,et al.  Instability of the Mitofusin Fzo1 Regulates Mitochondrial Morphology during the Mating Response of the Yeast Saccharomyces cerevisiae* , 2005, Journal of Biological Chemistry.

[736]  R. Pazdur,et al.  United States Food and Drug Administration Approval Summary: Bortezomib for the Treatment of Progressive Multiple Myeloma after One Prior Therapy , 2006, Clinical Cancer Research.

[737]  L. Ellerby,et al.  Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78 , 2002, FEBS letters.

[738]  E. Tani,et al.  Proteasome inhibitors induce Fas‐mediated apoptosis by c‐Myc accumulation and subsequent induction of FasL message in human glioma cells , 2001, FEBS letters.

[739]  S. W. Lin,et al.  Oxidatively denatured proteins are degraded by an ATP-independent proteolytic pathway in Escherichia coli. , 1988, Free radical biology & medicine.

[740]  L. Juliano,et al.  A structure‐based site‐directed mutagenesis study on the neurolysin (EC 3.4.24.16) and thimet oligopeptidase (EC 3.4.24.15) catalysis , 2003, FEBS letters.

[741]  J. White,et al.  Ceroid accumulation in a patient with progressive neurological disease. , 1968, Pediatrics.

[742]  A. Zhitkovich,et al.  Analysis of DNA-protein crosslinking activity of malondialdehyde in vitro. , 1999, Mutation research.

[743]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[744]  P. J. Elliot,et al.  Delayed Treatment of Ischemia/Reperfusion Brain Injury: Extended Therapeutic Window with the Proteosome Inhibitor MLN519 , 2004, Stroke.

[745]  P. Hasselgren,et al.  Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.

[746]  K. Fiebig,et al.  Backbone NMR Assignment of the Human E2 Ubiquitin Conjugating Enzyme UbcH5α (F72K,F82S) Double Mutant , 2005, Journal of Biomolecular NMR.

[747]  R. Vázquez-Manrique,et al.  Frataxin interacts functionally with mitochondrial electron transport chain proteins. , 2005, Human molecular genetics.

[748]  A. van Dorsselaer,et al.  Regeneration of Peroxiredoxins during Recovery after Oxidative Stress , 2003, Journal of Biological Chemistry.

[749]  Ze'ev Ronai,et al.  Role of redox potential and reactive oxygen species in stress signaling , 1999, Oncogene.

[750]  A. Goldberg,et al.  Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. , 1990, The Journal of biological chemistry.

[751]  P. Kloetzel,et al.  Tumor cell lines expressing the proteasome subunit isoform LMP7E1 exhibit immunoproteasome deficiency. , 2006, Cancer research.

[752]  R. Tampé,et al.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[753]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[754]  V. Bertholet,et al.  Comparison of replicative senescence and stress‐induced premature senescence combining differential display and low‐density DNA arrays , 2005, FEBS letters.

[755]  G. Dawson,et al.  Batten's disease: Clues to neuronal protein catabolism in lysosomes , 2000, Journal of neuroscience research.

[756]  E. Gravallese,et al.  Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. , 1995, Arthritis and rheumatism.

[757]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[758]  D. Cyr Arrest of CFTRΔF508 folding , 2005, Nature Structural &Molecular Biology.

[759]  U. Brunk,et al.  Is aging the price for memory? , 2005, Biogerontology.

[760]  L. Kuehn,et al.  Proteasome activator PA28 and its interaction with 20 S proteasomes. , 1996, Archives of biochemistry and biophysics.

[761]  T. Casoli,et al.  Morphometric investigations of the mitochondrial damage in ceroid lipopigment accumulation due to vitamin E deficiency. , 2002, Archives of gerontology and geriatrics.

[762]  J. Tyedmers,et al.  The Sec61p complex is a dynamic precursor activated channel. , 2003, Molecular cell.

[763]  U. Brunk,et al.  Lysosomes and oxidative stress in aging and apoptosis. , 2008, Biochimica et biophysica acta.

[764]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[765]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[766]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[767]  C. Kieling,et al.  A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3) , 2008, European journal of neurology.

[768]  K. Double,et al.  The comparative biology of neuromelanin and lipofuscin in the human brain , 2008, Cellular and Molecular Life Sciences.

[769]  P. Kloetzel,et al.  The components of the proteasome system and their role in MHC class I antigen processing. , 2003, Reviews of physiology, biochemistry and pharmacology.

[770]  K. Arai,et al.  Altered Heart Rate Control in Response to Postural Change in Patients with Machado–Joseph Disease (SCA3) , 2009, The Cerebellum.

[771]  C. Borner,et al.  Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice. , 1999, Melanoma research.

[772]  D. Thomas,et al.  The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. , 1999, Chemistry & biology.

[773]  B. Carter,et al.  TRAF6‐mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor , 2005, The EMBO journal.

[774]  A. Hunter,et al.  Proteasome inhibitor-induced apoptosis of B-chronic lymphocytic leukaemia cells involves cytochrome c release and caspase activation, accompanied by formation of an ∼700 kDa Apaf-1 containing apoptosome complex , 2001, Leukemia.

[775]  R. Austin,et al.  Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium: Implications in Atherogenesis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[776]  D. Kraut,et al.  To degrade or release: ubiquitin-chain remodeling. , 2007, Trends in cell biology.

[777]  K. Nakayama,et al.  Interaction of U‐box‐type ubiquitin‐protein ligases (E3s) with molecular chaperones , 2004, Genes to cells : devoted to molecular & cellular mechanisms.

[778]  J L Benovic,et al.  Role of Clathrin-mediated Endocytosis in Agonist-induced Down-regulation of the β2-Adrenergic Receptor* , 1998, The Journal of Biological Chemistry.

[779]  Sung Goo Park,et al.  Co-chaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes. , 2004, Biochemical and biophysical research communications.

[780]  S. Bassnett,et al.  Chromatin Degradation in Differentiating Fiber Cells of the Eye Lens , 1997, The Journal of cell biology.

[781]  P. Elliott,et al.  Early clinical experience with the novel proteasome inhibitor PS-519. , 2002, British journal of clinical pharmacology.

[782]  C. McCulloch,et al.  MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations. , 2006, Frontiers in bioscience : a journal and virtual library.

[783]  K. Wang,et al.  Calpain inhibition: an overview of its therapeutic potential. , 1994, Trends in pharmacological sciences.

[784]  A. Goldberg,et al.  The cytosolic endopeptidase, thimet oligopeptidase, destroys antigenic peptides and limits the extent of MHC class I antigen presentation. , 2003, Immunity.

[785]  Michael J. Ellison,et al.  Cdc34 Self-Association Is Facilitated by Ubiquitin Thiolester Formation and Is Required for Its Catalytic Activity , 2003, Molecular and Cellular Biology.

[786]  S. Akira,et al.  Integral role of Noxa in p53-mediated apoptotic response. , 2003, Genes & development.

[787]  Naoyuki Taniguchi,et al.  Dorfin Ubiquitylates Mutant SOD1 and Prevents Mutant SOD1-mediated Neurotoxicity* , 2002, The Journal of Biological Chemistry.

[788]  Yuichi Makino,et al.  Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway* , 1999, The Journal of Biological Chemistry.

[789]  Y. Nomura,et al.  Novel functions of ubiquitin ligase HRD1 with transmembrane and proline-rich domains. , 2008, Journal of pharmacological sciences.

[790]  T. Cotter,et al.  Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. , 2004, Biochimica et biophysica acta.

[791]  R. Nitsch,et al.  Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease , 2003, Journal of neurochemistry.

[792]  J. Lowe,et al.  Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins , 1996, Neuroscience Letters.

[793]  D. Wolf,et al.  Mutants of the deubiquitinating enzyme Ubp14 decipher pathway diversity of ubiquitin-proteasome linked protein degradation. , 2006, Biochemical and biophysical research communications.

[794]  R. Morimoto,et al.  Heat Shock Response and Protein Degradation: Regulation of HSF2 by the Ubiquitin-Proteasome Pathway , 1998, Molecular and Cellular Biology.

[795]  P. Price,et al.  Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. , 2006, The Journal of antimicrobial chemotherapy.

[796]  D. Cyr,et al.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation , 2000, Nature Cell Biology.

[797]  Ronald Wetzel,et al.  Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. , 2004, Molecular cell.

[798]  K. Wilkinson Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. , 2000, Seminars in cell & developmental biology.

[799]  B. Friguet,et al.  Protein maintenance in aging and replicative senescence: a role for the peptide methionine sulfoxide reductases. , 2005, Biochimica et biophysica acta.

[800]  Keiji Tanaka,et al.  Thymoproteasome: probable role in generating positively selecting peptides. , 2008, Current opinion in immunology.

[801]  B. Friguet,et al.  Methionine Sulfoxide Reductases , 2006, Annals of the New York Academy of Sciences.

[802]  T. Shearer,et al.  Calpain inhibitor, SJA6017, reduces the rate of formation of selenite cataract in rats , 2001, Current eye research.

[803]  M. Pandolfo,et al.  Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. , 1997, Science.

[804]  T. Lüscher,et al.  Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. , 1990, Hypertension.

[805]  U. Andley,et al.  Ubiquitin-activating enzyme (E1) isoforms in lens epithelial cells: origin of translation, E2 specificity and cellular localization determined with novel site-specific antibodies. , 2001, Experimental eye research.

[806]  R. Huber,et al.  Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. , 1995, Science.

[807]  M. Gurney,et al.  Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[808]  A. Milam,et al.  Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease). , 2004, Molecular genetics and metabolism.

[809]  Q. Dou,et al.  Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[810]  D. Glass,et al.  Molecular mechanisms modulating muscle mass. , 2003, Trends in molecular medicine.

[811]  A. Bachmair,et al.  PRT1 of Arabidopsis thaliana encodes a component of the plant N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[812]  R. Tampé,et al.  Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP , 2008, PLoS pathogens.

[813]  K. Davies,et al.  Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells , 2001, Cellular and Molecular Life Sciences CMLS.

[814]  V. Soldatenkov,et al.  Apoptosis of Ewing's sarcoma cells is accompanied by accumulation of ubiquitinated proteins. , 1997, Cancer research.

[815]  M. Glickman,et al.  Proteasome cerevisiae Saccharomyces The Regulatory Particle of the , 1997 .

[816]  A. Goldberg,et al.  Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. , 1999, The Journal of clinical investigation.

[817]  Tobias Jung,et al.  Distribution of oxidized and HNE‐modified proteins in U87 cells , 2005, BioFactors.

[818]  J. Brodsky,et al.  Molecular Chaperones in the Yeast Endoplasmic Reticulum Maintain the Solubility of Proteins for Retrotranslocation and Degradation , 2001, The Journal of cell biology.

[819]  L. Szweda,et al.  Aging: A shift from redox regulation to oxidative damage , 2006, Free radical research.

[820]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.

[821]  M. Moskowitz,et al.  Attenuated Neurotransmitter Release and Spreading Depression-Like Depolarizations after Focal Ischemia in Mutant Mice with Disrupted Type I Nitric Oxide Synthase Gene , 1998, The Journal of Neuroscience.

[822]  A. Bachmair,et al.  Arabidopsis thaliana RAD6 homolog AtUBC2 complements UV sensitivity, but not N-end rule degradation deficiency, of Saccharomyces cerevisiae rad6 mutants , 1997, Current Genetics.

[823]  S. Aaronson,et al.  BRCA2 Is Ubiquitinated In Vivo and Interacts with USP11, a Deubiquitinating Enzyme That Exhibits Prosurvival Function in the Cellular Response to DNA Damage , 2004, Molecular and Cellular Biology.

[824]  A. Likidlilid,et al.  Glutathione and glutathione peroxidase in type 1 diabetic patients. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[825]  Jianhua Liu,et al.  The N-degron approach to create temperature-sensitive mutants in Schizosaccharomyces pombe. , 2004, Methods.

[826]  C. Grant,et al.  Non‐reciprocal regulation of the redox state of the glutathione–glutaredoxin and thioredoxin systems , 2003, EMBO reports.

[827]  S. Salman,et al.  Oxidative protein damage in early stage Type 1 diabetic patients. , 2000, Diabetes research and clinical practice.

[828]  E. Mandelkow,et al.  The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments. , 2008, Biochemistry.

[829]  Hisashi Ito,et al.  Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. , 1996, Journal of biochemistry.

[830]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[831]  D. Hou,et al.  Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. , 2007, Free radical biology & medicine.

[832]  P. Zeitlin,et al.  Induction of HSP70 promotes ΔF508 CFTR trafficking , 2001 .

[833]  U. Schumacher,et al.  The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells. , 2007, Anticancer research.

[834]  R. Herbst,et al.  The proteasome inhibitor PS-341 in cancer therapy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[835]  M. Hendrix,et al.  Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells. , 2005, Cancer research.

[836]  Z. Ronai,et al.  Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis , 2000, Oncogene.

[837]  Tobias Jung,et al.  Intracellular distribution of oxidized proteins and proteasome in HT22 cells during oxidative stress. , 2006, Free radical biology & medicine.

[838]  R. Bhisitkul,et al.  Iron homeostasis and toxicity in retinal degeneration , 2007, Progress in Retinal and Eye Research.

[839]  J. Brodsky,et al.  Recognition and delivery of ERAD substrates to the proteasome and alternative paths for cell survival. , 2005, Current topics in microbiology and immunology.

[840]  Eunkyung Kim,et al.  Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules. , 2005, Biochemical and biophysical research communications.

[841]  M. Hayden,et al.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease , 1993, Nature Genetics.

[842]  Yifan Cheng,et al.  Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.

[843]  J. Holstege,et al.  CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.

[844]  K. Tanaka,et al.  Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. , 1994, Journal of biochemistry.

[845]  G. Goldstein,et al.  Molecular conservation of 74 amino acid sequence of ubiquitin between cattle and man , 1975, Nature.

[846]  P. Stambrook,et al.  Dominant negative c-jun inhibits activation of the cyclin D1 and cyclin E kinase complexes. , 2001, Molecular biology of the cell.

[847]  P. Kloetzel,et al.  Structure and structure formation of the 20S proteasome , 1997, Molecular Biology Reports.

[848]  C. Hill,et al.  Structure of the proteasome activator REGα (PA28α) , 1997, Nature.

[849]  O. Kaminuma,et al.  Transcriptional regulation of IL-5 gene by nontransformed human T cells through the proximal promoter element. , 2000, Internal medicine.

[850]  D. Green,et al.  A ‘non-canonical’ DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc , 2000, Current Biology.

[851]  D. Lockhart,et al.  Mitotic misregulation and human aging. , 2000, Science.

[852]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[853]  A. Goldberg,et al.  Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.

[854]  M. Kikuchi,et al.  Interactions among Yeast Protein-Disulfide Isomerase Proteins and Endoplasmic Reticulum Chaperone Proteins Influence Their Activities* , 2005, Journal of Biological Chemistry.

[855]  B. Barlogie,et al.  Extended follow‐up of a phase II trial in relapsed, refractory multiple myeloma: , 2006, Cancer.

[856]  T. Siddique,et al.  Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[857]  Tohru Natsume,et al.  A heterodimeric complex that promotes the assembly of mammalian 20S proteasomes , 2005, Nature.

[858]  J. Nobrega,et al.  Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.

[859]  H. Katinger,et al.  Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasome. , 2005, The Biochemical journal.

[860]  J. Tainer,et al.  Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. , 2002, Journal of molecular biology.

[861]  Takashi Uehara,et al.  A ubiquitin ligase HRD1 promotes the degradation of Pael receptor, a substrate of Parkin , 2006, Journal of neurochemistry.

[862]  F. Checler,et al.  Proteasome Inhibitors Prevent the Degradation of Familial Alzheimer ' s Disease-Linked Presenilin 1 and Potentiate A 1342 Recovery from Human Cells , 2007 .

[863]  K. Schulze-Osthoff,et al.  Irradiation-induced Translocation of p53 to Mitochondria in the Absence of Apoptosis* , 2005, Journal of Biological Chemistry.

[864]  Y. Ye,et al.  The Viral E3 Ubiquitin Ligase mK3 Uses the Derlin/p97 Endoplasmic Reticulum-associated Degradation Pathway to Mediate Down-regulation of Major Histocompatibility Complex Class I Proteins* , 2006, Journal of Biological Chemistry.

[865]  S. Oddo,et al.  The ubiquitin-proteasome system in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[866]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[867]  R. Plemper,et al.  Genetic interactions of Hrd3p and Der3p/Hrd1p with Sec61p suggest a retro-translocation complex mediating protein transport for ER degradation. , 1999, Journal of cell science.

[868]  Y. Ono,et al.  Phosphorylation of Tau Is Regulated by PKN* , 2001, The Journal of Biological Chemistry.

[869]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[870]  Leland Hartwell,et al.  Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells , 1992, Cell.

[871]  J. Riordan,et al.  Non-conventional Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator through the Early Secretory Pathway* , 2002, The Journal of Biological Chemistry.

[872]  H. Ploegh,et al.  Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[873]  C. Slaughter,et al.  PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. , 1994, The Journal of biological chemistry.

[874]  J. Marshall,et al.  Age-related maculopathy and the impact of blue light hazard. , 2006, Acta ophthalmologica Scandinavica.

[875]  C. Cotman,et al.  Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology , 1997, Journal of neuropathology and experimental neurology.

[876]  O. Niemelä,et al.  Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. , 2000, Journal of hepatology.

[877]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[878]  W. Mitch,et al.  Glucocorticoids Induce Proteasome C3 Subunit Expression in L6 Muscle Cells by Opposing the Suppression of Its Transcription by NF-κB* , 2000, The Journal of Biological Chemistry.

[879]  K. Davies,et al.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. , 2004, The international journal of biochemistry & cell biology.

[880]  S. Tsuji Dentatorubral-pallidoluysian atrophy (DRPLA). , 2020, Journal of neural transmission. Supplementum.

[881]  W. McBride,et al.  The Proteasome in Cancer Biology and Treatment , 2001, Radiation research.

[882]  I. Wada,et al.  EDEM As an Acceptor of Terminally Misfolded Glycoproteins Released from Calnexin , 2003, Science.

[883]  D. Moore Parkin: a multifaceted ubiquitin ligase. , 2006, Biochemical Society transactions.

[884]  J. Geatrell,et al.  Proteases in eye development and disease. , 2006, Birth defects research. Part C, Embryo today : reviews.

[885]  J. Davey,et al.  Endoplasmic reticulum-associated protein degradation. , 2000, Seminars in Cell and Developmental Biology.

[886]  M. Tisdale Wasting in cancer. , 1999, The Journal of nutrition.

[887]  Jeffrey L Brodsky,et al.  The Recognition and Retrotranslocation of Misfolded Proteins from the Endoplasmic Reticulum , 2008, Traffic.

[888]  K. Davies,et al.  Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. , 2005, Free radical biology & medicine.

[889]  P. Ferranti,et al.  Alteration in the ubiquitin structure and function in the human lens: a possible mechanism of senile cataractogenesis , 2002, FEBS letters.

[890]  W. Baumeister,et al.  Active Site-directed Inhibitors of Rhodococcus 20 S Proteasome , 1997, The Journal of Biological Chemistry.

[891]  B. Friguet,et al.  Proteolysis, free radicals, and aging. , 2002, Free radical biology & medicine.

[892]  Minoru Funakoshi,et al.  A multimeric assembly factor controls the formation of alternative 20S proteasomes , 2008, Nature Structural &Molecular Biology.

[893]  Bertrand Friguet,et al.  Impact of ageing on proteasome structure and function in human lymphocytes. , 2003, The international journal of biochemistry & cell biology.

[894]  P. Fürst,et al.  Proteasome- and p38-dependent Regulation of ERK3 Expression* , 2001, The Journal of Biological Chemistry.

[895]  F. Shang,et al.  Ubiquitin-dependent pathway is up-regulated in differentiating lens cells. , 1999, Experimental eye research.

[896]  Kai Du,et al.  Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. , 2005, The Journal of clinical investigation.

[897]  S. Ganesan,et al.  Mutant SOD1 detoxification mechanisms in intact single cells , 2008, Cell Death and Differentiation.

[898]  W. Reith,et al.  Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[899]  D. Wolf,et al.  The Active Sites of the Eukaryotic 20 S Proteasome and Their Involvement in Subunit Precursor Processing* , 1997, The Journal of Biological Chemistry.

[900]  K Tanaka,et al.  Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.

[901]  F. Luciani,et al.  A mathematical model of protein degradation by the proteasome. , 2005, Biophysical journal.

[902]  A. Ciechanover,et al.  Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes , 1995, Molecular and cellular biology.

[903]  E. Feldman,et al.  Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. , 1999, European journal of pharmacology.

[904]  Wen-Lang Lin,et al.  Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.

[905]  V. Gladyshev,et al.  Methionine Sulfoxide Reduction and the Aging Process , 2007, Annals of the New York Academy of Sciences.

[906]  S. Matalon,et al.  Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. , 2006, Free radical biology & medicine.

[907]  G. Tiao,et al.  Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. , 1994, The Journal of clinical investigation.

[908]  C. Marsden,et al.  Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.

[909]  G. Tiao,et al.  Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. , 1998, The American journal of physiology.

[910]  K. Thennarasu,et al.  Spinocerebellar ataxias types 1, 2 and 3: Age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths , 2009, Journal of the Neurological Sciences.

[911]  N. Shibata,et al.  Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene , 2005, Acta Neuropathologica.

[912]  John S. Mattick,et al.  The Ras Target AF-6 is a Substrate of the Fam Deubiquitinating Enzyme , 1998, The Journal of cell biology.

[913]  P. A. Peterson,et al.  In Vivo Characterization of the Proteasome Regulator PA28* , 1996, The Journal of Biological Chemistry.

[914]  S. Skatchkov,et al.  Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. , 2009, DNA repair.

[915]  A H Schapira,et al.  Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse , 2000, Annals of neurology.

[916]  P. D'Arpa,et al.  Ubiquitin-dependent Destruction of Topoisomerase I Is Stimulated by the Antitumor Drug Camptothecin* , 1997, The Journal of Biological Chemistry.

[917]  J. Estrela,et al.  Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. , 1994, Cancer research.

[918]  C. Haass,et al.  Endoplasmic reticulum retention of the γ‐secretase complex component Pen2 by Rer1 , 2007 .

[919]  Soyeon Park,et al.  Docking of the proteasomal ATPases' carboxyl termini in the 20S proteasome's alpha ring opens the gate for substrate entry. , 2007, Molecular cell.

[920]  E. Stadtman,et al.  Oxidation of Methionine in Proteins: Roles in Antioxidant Defense and Cellular Regulation , 2000, IUBMB life.

[921]  R. Aebersold,et al.  Proteomics Analysis of Cellular Response to Oxidative Stress , 2002, The Journal of Biological Chemistry.

[922]  C. Broeckhoven,et al.  Alzheimer's Disease Associated Presenilin 1 Interacts with HC5 and ZETA, Subunits of the Catalytic 20S Proteasome , 1999, Neurobiology of Disease.

[923]  C. Slaughter,et al.  A Model for the Quaternary Structure of the Proteasome Activator PA28* , 1996, The Journal of Biological Chemistry.

[924]  C. Crews,et al.  Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[925]  H. Ploegh,et al.  SEL1L, the homologue of yeast Hrd3p, is involved in protein dislocation from the mammalian ER , 2006, The Journal of cell biology.

[926]  D. Phoenix,et al.  Calpains: targets of cataract prevention? , 2004, Trends in molecular medicine.

[927]  P. Kloetzel,et al.  A structural model of 20S immunoproteasomes: effect of LMP2 codon 60 polymorphism on expression, activity, intracellular localisation and insight into the regulatory mechanisms , 2006, Biological chemistry.

[928]  V. Medici,et al.  M-30 and 4HNE are sequestered in different aggresomes in the same hepatocytes. , 2007, Experimental and molecular pathology.

[929]  U. Brunk,et al.  Autophagy, organelles and ageing , 2007, The Journal of pathology.

[930]  T. Zglinicki,et al.  Protein oxidation and degradation during proliferative senescence of human MRC-5 fibroblasts. , 2000, Free radical biology & medicine.

[931]  V. Baracos,et al.  Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. , 1989, The American journal of physiology.

[932]  Aaron Ciechanover,et al.  The Ubiquitin Proteasome System in Neurodegenerative Diseases Sometimes the Chicken, Sometimes the Egg , 2003, Neuron.

[933]  C. Rodighiero,et al.  Protein Disulfide Isomerase Acts as a Redox-Dependent Chaperone to Unfold Cholera Toxin , 2001, Cell.

[934]  D. Taillandier,et al.  Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia , 1999, Molecular Biology Reports.

[935]  A. Boulares,et al.  Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: Differential requirement for PARP-1 expression and interaction. , 2008, Cellular signalling.

[936]  C. Borchers,et al.  Regulation of the Cytoplasmic Quality Control Protein Degradation Pathway by BAG2* , 2005, Journal of Biological Chemistry.

[937]  B. Ruebner,et al.  Sequential acetaldehyde production, lipid peroxidation, and fibrogenesis in micropig model of alcohol‐induced liver disease , 1995, Hepatology.

[938]  Donna D. Zhang Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway , 2006, Drug metabolism reviews.

[939]  D. Esseltine,et al.  A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma , 2004, British journal of haematology.

[940]  G. Cagney,et al.  Proteasome involvement in the repair of DNA double-strand breaks. , 2004, Molecular cell.

[941]  C. Slaughter,et al.  Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). , 1992, The Journal of biological chemistry.

[942]  W. Baumeister,et al.  Expression of functional Thermoplasma acidophilum proteasomes in Escherichia coli , 1992, FEBS letters.

[943]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[944]  G. Semenza,et al.  HIF-1 and human disease: one highly involved factor. , 2000, Genes & development.

[945]  C. Broeckhoven,et al.  Spinocerebellar ataxia type 7 (SCA7): widespread brain damage in an adult‐onset patient with progressive visual impairments in comparison with an adult‐onset patient without visual impairments , 2008, Neuropathology and applied neurobiology.

[946]  T. Rapoport,et al.  The ER‐associated degradation component Der1p and its homolog Dfm1p are contained in complexes with distinct cofactors of the ATPase Cdc48p , 2008, FEBS letters.

[947]  D. Finley,et al.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.

[948]  James Rader,et al.  Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[949]  Miao Zhang,et al.  Proteasome-Dependent Degradation of Guanosine 5-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus , 2007, Circulation.

[950]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[951]  C. Lo,et al.  Connexins and cell signaling in development and disease. , 2004, Annual review of cell and developmental biology.

[952]  Michael S. Wolfe,et al.  Presenilin: Running with Scissors in the Membrane , 2007, Cell.

[953]  T. Ogihara,et al.  Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model , 1999, Gene Therapy.

[954]  S. Korsmeyer,et al.  Death and survival signals determine active/inactive conformations of pro-apoptotic BAX, BAD, and BID molecules. , 1999, Cold Spring Harbor symposia on quantitative biology.

[955]  C. Fletcher,et al.  Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease , 2002, Nature Genetics.

[956]  Maurizio Molinari,et al.  A Novel Stress-induced EDEM Variant Regulating Endoplasmic Reticulum-associated Glycoprotein Degradation* , 2005, Journal of Biological Chemistry.

[957]  A. Tiwari,et al.  Familial Amyotrophic Lateral Sclerosis Mutants of Copper/Zinc Superoxide Dismutase Are Susceptible to Disulfide Reduction* , 2003, The Journal of Biological Chemistry.

[958]  G. Lozano,et al.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. , 1990, Science.

[959]  K. Nakayama,et al.  U‐box protein carboxyl terminus of Hsc70‐interacting protein (CHIP) mediates poly‐ubiquitylation preferentially on four‐repeat Tau and is involved in neurodegeneration of tauopathy , 2004, Journal of neurochemistry.

[960]  H. Drexler Activation of the cell death program by inhibition of proteasome function. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[961]  M. Figueiredo-Pereira,et al.  Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition. , 2004, Biochemical and biophysical research communications.

[962]  R. Tiozzo,et al.  Proteome analysis of dermal fibroblasts cultured in vitro from human healthy subjects of different ages , 2003, Proteomics.

[963]  R. Wojcikiewicz,et al.  Involvement of the p97-Ufd1-Npl4 Complex in the Regulated Endoplasmic Reticulum-associated Degradation of Inositol 1,4,5-Trisphosphate Receptors* , 2005, Journal of Biological Chemistry.

[964]  N. Chondrogianni,et al.  Proteasome dysfunction in mammalian aging: Steps and factors involved , 2005, Experimental Gerontology.

[965]  S. Ikehara,et al.  Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line. , 2001, Oncology reports.

[966]  V. Chau,et al.  Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[967]  Martin Scheffner,et al.  Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. , 2003, Seminars in cancer biology.

[968]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[969]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[970]  M. Wick,et al.  A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation , 1998 .

[971]  A. Dancis,et al.  Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. , 2007, Free radical biology & medicine.

[972]  J. Lucas,et al.  Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtin , 2009, Neurotoxicity Research.

[973]  N. Osna,et al.  Implication of altered proteasome function in alcoholic liver injury. , 2007, World journal of gastroenterology.

[974]  T. A. Griffin,et al.  Protein-protein interactions among human 20S proteasome subunits and proteassemblin. , 2004, Biochemical and biophysical research communications.

[975]  R. Kopito,et al.  Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.

[976]  S. Varambally,et al.  Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition , 2007, Proceedings of the National Academy of Sciences.

[977]  P. Bongioanni,et al.  Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease. , 2004, The Cochrane database of systematic reviews.

[978]  X. Matías-Guiu,et al.  Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma‐derived cell lines , 2008, The British journal of dermatology.

[979]  K. Früh,et al.  Antigen presentation by MHC class I and its regulation by interferon gamma. , 1999, Current opinion in immunology.

[980]  A. Steven,et al.  The axial channel of the 20S proteasome opens upon binding of the PA200 activator. , 2005, Journal of molecular biology.

[981]  S. Grotegut,et al.  Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation. , 2006, International journal of biological macromolecules.

[982]  N. Mizushima,et al.  Role of the Apg12 conjugation system in mammalian autophagy. , 2003, The international journal of biochemistry & cell biology.

[983]  C. Nordgaard,et al.  Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.

[984]  A. Goldberg,et al.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.

[985]  C. Rondinone,et al.  Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. , 2001, Diabetes.

[986]  J. Dunaief Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. , 2006, Investigative ophthalmology & visual science.

[987]  W. Duckworth,et al.  Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. , 2003, The Journal of endocrinology.

[988]  P. Kloetzel,et al.  Biochemical analysis of proteasomes from mouse microglia: Induction of immunoproteasomes by interferon‐γ and lipopolysaccharide , 2000, Glia.

[989]  Keiji Tanaka,et al.  Critical role of PA28γ in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis , 2007, Proceedings of the National Academy of Sciences.

[990]  J. Yewdell Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. , 2001, Trends in cell biology.

[991]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[992]  A. Griswold,et al.  Overexpression of frataxin in the mitochondria increases resistance to oxidative stress and extends lifespan in Drosophila , 2008, FEBS letters.

[993]  D. Ng,et al.  Search and Destroy: ER Quality Control and ER-Associated Protein Degradation , 2005, Critical reviews in biochemistry and molecular biology.

[994]  Jong-Bok Yoon,et al.  TRIP12 functions as an E3 ubiquitin ligase of APP-BP1. , 2008, Biochemical and biophysical research communications.

[995]  B. Friguet,et al.  Age-dependent protein modifications and declining proteasome activity in the human lens. , 2004, Archives of biochemistry and biophysics.

[996]  E. Boerwinkle,et al.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. , 2003, Circulation.

[997]  K D Wilkinson,et al.  The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.

[998]  P. Kloetzel,et al.  Immunoproteasome subunit LMP2 expression is deregulated in Sjögren’s syndrome but not in other autoimmune disorders , 2006, Annals of the rheumatic diseases.

[999]  T. Rapoport,et al.  A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol , 2004, Nature.

[1000]  H. Meyer,et al.  Role(s) of Cdc48/p97 in mitosis. , 2008, Biochemical Society transactions.

[1001]  E. Stadtman,et al.  Oxidation of methionine residues of proteins: biological consequences. , 2003, Antioxidants & redox signaling.

[1002]  Krista Fleck,et al.  Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD. , 2008, Experimental cell research.

[1003]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[1004]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition , 2001 .

[1005]  R. Kraft,et al.  Mammalian Sec61 Is Associated with Sec62 and Sec63* , 2000, The Journal of Biological Chemistry.

[1006]  Weiming Xia,et al.  From presenilinase to gamma-secretase, cleave to capacitate. , 2008, Current Alzheimer research.

[1007]  P. Fraser,et al.  Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and α-Synuclein* , 2006, Journal of Biological Chemistry.

[1008]  J. Hahn,et al.  A stress regulatory network for co‐ordinated activation of proteasome expression mediated by yeast heat shock transcription factor , 2006, Molecular microbiology.

[1009]  K. Nakayama,et al.  U-box proteins as a new family of ubiquitin ligases. , 2003, Biochemical and biophysical research communications.

[1010]  R. Huber,et al.  Isolation and characterization of the prokaryotic proteasome homolog HslVU (ClpQY) from Thermotoga maritima and the crystal structure of HslV. , 2002, Biophysical chemistry.

[1011]  R. Kopito,et al.  Biosynthesis and degradation of CFTR. , 1999, Physiological reviews.

[1012]  D. Waxman,et al.  Termination of growth hormone pulse-induced STAT5b signaling. , 1999, Molecular endocrinology.

[1013]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[1014]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[1015]  K. Sugimura,et al.  Ionizing Radiation Induces a p53-dependent Apoptotic Mechanism in ARPE-19 Cells , 2004, Japanese Journal of Ophthalmology.

[1016]  H. Söling,et al.  The protein disulphide-isomerase family: unravelling a string of folds. , 1999, The Biochemical journal.

[1017]  P. Kloetzel,et al.  Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexes. , 1997, Journal of molecular biology.

[1018]  T. Dawson Parkin and defective ubiquitination in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[1019]  A. Ciechanover,et al.  Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2. , 1994, The Journal of biological chemistry.

[1020]  C. Wójcik,et al.  Ubiquitin-Proteasome System and Proteasome Inhibition: New Strategies in Stroke Therapy , 2004, Stroke.

[1021]  Jae Sung Hwang,et al.  Age-associated decrease in proteasome content and activities in human dermal fibroblasts: restoration of normal level of proteasome subunits reduces aging markers in fibroblasts from elderly persons. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[1022]  I. A. Rose,et al.  Mechanism of ubiquitin carboxyl-terminal hydrolase. Borohydride and hydroxylamine inactivate in the presence of ubiquitin. , 1986, The Journal of biological chemistry.

[1023]  Y. Itoyama,et al.  NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1* , 2004, Journal of Biological Chemistry.

[1024]  Joan E. Roberts,et al.  Spectroscopic properties and reactivity of free radical forms of A2E. , 2005, Free radical biology & medicine.

[1025]  J. Andersen,et al.  Redox imbalance in Parkinson's disease. , 2008, Biochimica et biophysica acta.

[1026]  J. Elliott,et al.  Non-neuronal induction of immunoproteasome subunits in an ALS model: Possible mediation by cytokines , 2005, Experimental Neurology.

[1027]  J. Schmid,et al.  BMS-345541 Targets Inhibitor of κB Kinase and Induces Apoptosis in Melanoma: Involvement of Nuclear Factor κB and Mitochondria Pathways , 2006, Clinical Cancer Research.

[1028]  L. Baliko,et al.  Spinocerebellar Ataxia Types 1, 2, 3 and 6: the Clinical Spectrum of Ataxia and Morphometric Brainstem and Cerebellar Findings , 2008, The Cerebellum.

[1029]  K. Davies Protein damage and degradation by oxygen radicals. I. general aspects. , 1987, The Journal of biological chemistry.

[1030]  C. Duve The lysosome turns fifty , 2005, Nature Cell Biology.

[1031]  D. Phoenix,et al.  The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017 , 2004, Molecular and Cellular Biochemistry.

[1032]  Ming Yan,et al.  Ube1L and Protein ISGylation Are Not Essential for Alpha/Beta Interferon Signaling , 2006, Molecular and Cellular Biology.

[1033]  R. Marfella,et al.  The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment. , 2006, Diabetes.

[1034]  E A Zemskov,et al.  Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. , 2001, Human molecular genetics.

[1035]  T. Gunatilaka,et al.  The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[1036]  F. Schweisguth,et al.  Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1037]  Fiona Crawford,et al.  Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo , 1998, Neuroscience Letters.

[1038]  JB Almond,et al.  The proteasome: a novel target for cancer chemotherapy , 2002, Leukemia.

[1039]  Wim J. N. Meester,et al.  Small‐Molecule Inhibitors and Probes for Ubiquitin‐ and Ubiquitin‐Like‐Specific Proteases , 2005, Chembiochem : a European journal of chemical biology.

[1040]  K. Hofmann,et al.  Activating the ubiquitin family: UBA6 challenges the field. , 2008, Trends in biochemical sciences.

[1041]  Mingsheng Zhang,et al.  Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin‐independent substrate , 2003, The EMBO journal.

[1042]  P. Glees,et al.  Lipofuscin in neuronal aging and diseases. , 1976, Normale und pathologische Anatomie.

[1043]  Min Jae Lee,et al.  A Family of Mammalian E3 Ubiquitin Ligases That Contain the UBR Box Motif and Recognize N-Degrons , 2005, Molecular and Cellular Biology.

[1044]  R. Dohmen,et al.  Role of C-terminal Extensions of Subunits β2 and β7 in Assembly and Activity of Eukaryotic Proteasomes* , 2004, Journal of Biological Chemistry.

[1045]  P. Braquet,et al.  The role of PAF in immunological responses: a review. , 1987, Prostaglandins.

[1046]  M. Hochstrasser Lingering Mysteries of Ubiquitin-Chain Assembly , 2006, Cell.

[1047]  J. Roth,et al.  Protein quality control: the who’s who, the where’s and therapeutic escapes , 2007, Histochemistry and Cell Biology.

[1048]  M. Rechsteiner,et al.  Molecular dissection of the 11S REG (PA28) proteasome activators. , 2001, Biochimie.

[1049]  O. Isacson,et al.  Generalized brain and skin proteasome inhibition in Huntington's disease , 2004, Annals of neurology.

[1050]  M. Tisdale,et al.  Cancer anorexia and cachexia. , 2001, Nutrition.

[1051]  A. Zeiher,et al.  Ubiquitin-mediated Degradation of the Proapoptotic Active Form of Bid , 2000, The Journal of Biological Chemistry.

[1052]  E. Medrano,et al.  Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes , 2000, Experimental Gerontology.

[1053]  M. Herlyn,et al.  Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[1054]  M. Shirakawa,et al.  Structure of the UBA domain of Dsk2p in complex with ubiquitin molecular determinants for ubiquitin recognition. , 2005, Structure.

[1055]  Tobias Jung,et al.  Oxidized proteins: intracellular distribution and recognition by the proteasome. , 2007, Archives of biochemistry and biophysics.

[1056]  Joshua M. Shulman,et al.  Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles , 2001, Science.

[1057]  N. Nukina,et al.  Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction. , 2006, Biochemical and biophysical research communications.

[1058]  R. Galassi,et al.  Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. , 1994, Metabolism: clinical and experimental.

[1059]  D. Louis,et al.  The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. , 1998, Molecular cell.

[1060]  U. Lopes,et al.  p53-dependent Induction of Apoptosis by Proteasome Inhibitors* , 1997, The Journal of Biological Chemistry.

[1061]  E. Masliah,et al.  alpha-Synuclein aggregates interfere with Parkin solubility and distribution: role in the pathogenesis of Parkinson disease. , 2008, The Journal of biological chemistry.

[1062]  Jean X. Jiang,et al.  The Development-associated Cleavage of Lens Connexin 45.6 by Caspase-3-like Protease Is Regulated by Casein Kinase II-mediated Phosphorylation* , 2001, The Journal of Biological Chemistry.

[1063]  G. Demartino,et al.  Aggregate formation in the spinal cord of mutant SOD1 transgenic mice is reversible and mediated by proteasomes , 2003, Journal of neurochemistry.

[1064]  Wolfram Tempel,et al.  Mechanism of Class 1 (Glycosylhydrolase Family 47) α-Mannosidases Involved in N-Glycan Processing and Endoplasmic Reticulum Quality Control* , 2005, Journal of Biological Chemistry.

[1065]  P. Libby,et al.  Inflammation and Atherosclerosis , 2002, Circulation.

[1066]  Rebecca A. Roberts Lysosomal cysteine proteases: structure, function and inhibition of cathepsins. , 2005, Drug news & perspectives.

[1067]  C. Acquaviva,et al.  Complex mechanisms for c-fos and c-jun degradation , 1997, Molecular Biology Reports.

[1068]  B. Ponder,et al.  Involvement of Brca2 in DNA repair. , 1998, Molecular cell.

[1069]  M. Rechsteiner,et al.  PA200, a nuclear proteasome activator involved in DNA repair , 2002, The EMBO journal.

[1070]  N. Agell,et al.  Muscle wasting associated with cancer cachexia is linked to an important activation of the atp‐dependent ubiquitin‐mediated proteolysis , 1995, International journal of cancer.

[1071]  T. Rapoport Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes , 2007, Nature.

[1072]  A. García-Sastre,et al.  Mice Lacking the ISG15 E1 Enzyme UbE1L Demonstrate Increased Susceptibility to both Mouse-Adapted and Non-Mouse-Adapted Influenza B Virus Infection , 2008, Journal of Virology.

[1073]  E. Stadtman,et al.  Metal-catalyzed oxidation of proteins. Physiological consequences. , 1991, The Journal of biological chemistry.

[1074]  C. Harris,et al.  Distinct pattern of p53 phosphorylation in human tumors , 2001, Oncogene.

[1075]  D. Harman Free radical theory of aging: dietary implications , 1972 .

[1076]  P. Roepstorff,et al.  Transcriptome and Proteome Analysis in Human Senescent Fibroblasts and Fibroblasts Undergoing Premature Senescence Induced by Repeated Sublethal Stresses , 2000, Annals of the New York Academy of Sciences.

[1077]  Mingsheng Zhang,et al.  Probing the ubiquitin/proteasome system with ornithine decarboxylase, a ubiquitin-independent substrate. , 2005, Methods in enzymology.

[1078]  F. Shang,et al.  Oxidative stress and recovery from oxidative stress are associated with altered ubiquitin conjugating and proteolytic activities in bovine lens epithelial cells. , 1995, The Biochemical journal.

[1079]  P. Elliott,et al.  26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer , 2001, Journal of cellular biochemistry.

[1080]  U. Brunk,et al.  Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis , 1998, Mechanisms of Ageing and Development.

[1081]  Keiji Tanaka The proteasome: Overview of structure and functions , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[1082]  M. Ward,et al.  Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1083]  P. Walter,et al.  Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.

[1084]  J. Blumberg,et al.  Regulation of Ubiquitin-conjugating Enzymes by Glutathione Following Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[1085]  D. Richardson,et al.  Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. , 2001, The international journal of biochemistry & cell biology.

[1086]  R. Hampton ER-associated degradation in protein quality control and cellular regulation. , 2002, Current opinion in cell biology.

[1087]  R. Huber,et al.  A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism , 2008, Nature.

[1088]  Elke Krüger,et al.  The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum , 2007, EMBO reports.

[1089]  G. Burmester,et al.  Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndrome. , 2006, Arthritis and rheumatism.

[1090]  J. de Jersey,et al.  Detection of stable acetaldehyde-modified proteins in the livers of ethanol-fed rats. , 1991, Alcohol and alcoholism.

[1091]  M. Fortini,et al.  Genetic analysis of the role of the drosophila fat facets gene in the ubiquitin pathway. , 1999, Developmental genetics.

[1092]  B. Friguet,et al.  Protein Degradation by the Proteasome and Its Implications in Aging , 2000, Annals of the New York Academy of Sciences.

[1093]  R F Standaert,et al.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin , 1995, Science.

[1094]  K. Kosik,et al.  CHIP and HSPs interact with β-APP in a proteasome-dependent manner and influence Aβ metabolism , 2007 .

[1095]  Keiji Tanaka,et al.  Expression of subunits of the 19S complex and of the PA28 activator in rat skeletal muscle , 1997, Molecular Biology Reports.

[1096]  M. Bogyo,et al.  Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1097]  D. Wolf,et al.  Ubiquitin Ligase Hul5 Is Required for Fragment-specific Substrate Degradation in Endoplasmic Reticulum-associated Degradation* , 2008, Journal of Biological Chemistry.

[1098]  Zekun Guo,et al.  Human Aurora-B binds to a proteasome α-subunit HC8 and undergoes degradation in a proteasome-dependent manner , 2003, Molecular and Cellular Biochemistry.

[1099]  K. Anderson,et al.  Clinical update: novel targets in multiple myeloma. , 2004, Seminars in oncology.

[1100]  T. Grune,et al.  Proteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts , 1998, FEBS letters.

[1101]  D. Schenkein Proteasome inhibitors in the treatment of B-cell malignancies. , 2002, Clinical lymphoma.

[1102]  B. Monsarrat,et al.  Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation1 , 2006, The Journal of Immunology.

[1103]  R. Huber,et al.  Bivalency as a principle for proteasome inhibition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1104]  S. Lovestone,et al.  Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells , 2001, Neuroscience.

[1105]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[1106]  D. L. Coppock,et al.  Generating Disulfides in Multicellular Organisms: Emerging Roles for a New Flavoprotein Family* , 2007, Journal of Biological Chemistry.

[1107]  Lei Guo,et al.  COUP-TF1 Antagonizes Nkx2.5-mediated Activation of the Calreticulin Gene during Cardiac Development* , 2001, The Journal of Biological Chemistry.

[1108]  M. Ohira,et al.  A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner , 2008, Oncogene.

[1109]  A. Varshavsky,et al.  Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin‐mediated proteolysis in Saccharomyces cerevisiae. , 1996, The EMBO journal.

[1110]  J. Broers,et al.  Detailed analysis of cell cycle kinetics upon proteasome inhibition. , 1997, Cytometry.

[1111]  H. Sies,et al.  Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.

[1112]  I. Chantret,et al.  Free-oligosaccharide control in the yeast Saccharomyces cerevisiae: roles for peptide:N-glycanase (Png1p) and vacuolar mannosidase (Ams1p). , 2003, The Biochemical journal.

[1113]  A. Dancis,et al.  Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). , 2003, Human molecular genetics.

[1114]  H. Banjar Mortality data for cystic fibrosis patients in a tertiary care center in Saudi Arabia. , 2003, Annals of Saudi medicine.

[1115]  P. Silver,et al.  The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. , 2001, Molecular biology of the cell.

[1116]  D. Harman Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.

[1117]  K. Schwarz,et al.  Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why? , 2001 .

[1118]  I. Wada,et al.  A novel ER α‐mannosidase‐like protein accelerates ER‐associated degradation , 2001 .

[1119]  K. Davies,et al.  Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis. , 1986, Journal of free radicals in biology & medicine.

[1120]  Lee Sp,et al.  Ceroid enteropathy and vitamin E deficiency. , 1976 .

[1121]  A. Rivett,et al.  Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins. , 2004, Current protein & peptide science.

[1122]  G. Paolisso,et al.  Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment. , 2006, Journal of the American College of Cardiology.

[1123]  L. Dick,et al.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. , 1998, Bioorganic & medicinal chemistry letters.

[1124]  J. Yewdell,et al.  CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.

[1125]  E. Stadtman,et al.  Methionine residues as endogenous antioxidants in proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[1126]  K. Takahashi,et al.  TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities. , 2000, The Journal of antibiotics.

[1127]  A. Medhurst,et al.  Proteasomal activity in brain differs between species and brain regions and changes with age , 2005, Mechanisms of Ageing and Development.

[1128]  Claudio Realini,et al.  KEKE motifs , 1994, FEBS letters.

[1129]  R. Huber,et al.  Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor. , 2001, Journal of molecular biology.

[1130]  A. Goldberg,et al.  Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[1131]  I. Noher de Halac,et al.  Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses. , 2005, Clinical biochemistry.

[1132]  J. Connor,et al.  Developmental, regional, and cellular expression of SFT/UbcH5A and DMT1 mRNA in brain , 2004, Journal of neuroscience research.

[1133]  J. Keller,et al.  Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome? , 2006, Free radical biology & medicine.

[1134]  Qingbo Xu,et al.  Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. , 1993, The American journal of pathology.

[1135]  A. Luder,et al.  LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[1136]  B. Friguet,et al.  Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.

[1137]  P. Jenner,et al.  Oxidative stress in Parkinson's disease and other neurodegenerative disorders. , 1996, Pathologie-biologie.

[1138]  D. Battleman,et al.  Utility of bortezomib retreatment in relapsed or refractory multiple myeloma patients: a multicenter case series. , 2008, Clinical advances in hematology & oncology : H&O.

[1139]  M. Rechsteiner,et al.  The Proteasome Activator 11 S Regulator or PA28 , 1998, The Journal of Biological Chemistry.

[1140]  Pietro Fratta,et al.  Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. , 2005, The American journal of pathology.

[1141]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[1142]  D. Tuma Role of malondialdehyde-acetaldehyde adducts in liver injury. , 2002, Free radical biology & medicine.

[1143]  K. Davies,et al.  Peroxynitrite Increases the Degradation of Aconitase and Other Cellular Proteins by Proteasome* , 1998, The Journal of Biological Chemistry.

[1144]  Aubrey D.N.J. de Grey,et al.  HO2*: the forgotten radical. , 2002 .

[1145]  Keiji Tanaka,et al.  Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes , 2007, Science.

[1146]  D. Schmechel Art, alpha-1-antitrypsin polymorphisms and intense creative energy: blessing or curse? , 2007, Neurotoxicology.

[1147]  A. Cuervo,et al.  Degradation of proteasomes by lysosomes in rat liver. , 1995, European journal of biochemistry.

[1148]  R. Krug,et al.  Properties of the ISG15 E1 enzyme UbE1L. , 2005, Methods in enzymology.

[1149]  M. Ator,et al.  P'-extended α-ketoamide inhibitors of proteasome , 1999 .

[1150]  D. Yin,et al.  Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores. , 1996, Free radical biology & medicine.

[1151]  Christine Kim,et al.  Endoplasmic Reticulum Degradation Requires Lumen to Cytosol Signaling , 2000, The Journal of cell biology.

[1152]  S. Price,et al.  Proteolysis, the ubiquitin-proteasome system, and renal diseases. , 2003, American journal of physiology. Renal physiology.

[1153]  P. Drain,et al.  Derlin-1 Promotes the Efficient Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and CFTR Folding Mutants* , 2006, Journal of Biological Chemistry.

[1154]  S. Elledge,et al.  How the Cyclin Became a Cyclin Regulated Proteolysis in the Cell Cycle , 1999, Cell.

[1155]  M. Pariat,et al.  Ubiquitinylation is not an absolute requirement for degradation of c- Jun protein by the 26 S proteasome , 1995, The Journal of Biological Chemistry.

[1156]  G. Ginsburg,et al.  Integrating diagnostics and therapeutics: revolutionizing drug discovery and patient care. , 2002, Drug discovery today.

[1157]  T. Reinheckel,et al.  Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1158]  R. Huber,et al.  Inhibitors of the eukaryotic 20S proteasome core particle: a structural approach. , 2004, Biochimica et biophysica acta.

[1159]  N. Agell,et al.  TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. , 1997, Biochemical and biophysical research communications.

[1160]  P. Elliott,et al.  Proteasome inhibition: A novel mechanism to combat asthma. , 1999, The Journal of allergy and clinical immunology.

[1161]  J. Ávila,et al.  Characterization of Alzheimer paired helical filaments by electron microscopy , 2005, Microscopy research and technique.

[1162]  R. Tennant,et al.  Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis* , 2003, The Journal of Biological Chemistry.

[1163]  N. Agell,et al.  Ubiquitin Gene Expression in Skeletal Muscle Is Increased by Tumor Necrosis Factor-α , 1994 .

[1164]  T. D. Manna,et al.  O diabetes melito na fibrose cística: uma comorbidade cada vez mais freqüente , 2008 .

[1165]  D. Delia,et al.  The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI , 2001, British journal of haematology.

[1166]  E. Barrett,et al.  Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle. , 1992, The Journal of clinical investigation.

[1167]  A. Ciechanover,et al.  Nuclear localization of the ubiquitin-activating enzyme, E1, is cell-cycle-dependent. , 1994, The Biochemical journal.

[1168]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[1169]  T. Nicotera,et al.  Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.

[1170]  T. Grune Oxidative stress, aging and the proteasomal system , 2004, Biogerontology.

[1171]  M. Rechsteiner,et al.  Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL. , 2006, Molecular immunology.

[1172]  Jesús Avila,et al.  Tau phosphorylation and aggregation in Alzheimer's disease pathology , 2006, FEBS letters.

[1173]  M. Mahowald,et al.  Evaluation of sleep and daytime somnolence in spinocerebellar ataxia type 6 (SCA6) , 2006, Neurology.

[1174]  N. Shibata,et al.  Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. , 1996, Developmental neuroscience.

[1175]  Isidro Ferrer,et al.  Neuronal Induction of the Immunoproteasome in Huntington's Disease , 2003, The Journal of Neuroscience.

[1176]  Raymond J. Deshaies,et al.  Mechanism of Lysine 48-Linked Ubiquitin-Chain Synthesis by the Cullin-RING Ubiquitin-Ligase Complex SCF-Cdc34 , 2005, Cell.

[1177]  R. Seipelt,et al.  Proteasome inhibition alters the transcription of multiple yeast genes. , 2004, Biochimica et biophysica acta.

[1178]  M. Orłowski,et al.  The multicatalytic proteinase complex, a major extralysosomal proteolytic system. , 1990, Biochemistry.

[1179]  J. Camadro,et al.  Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia. , 2008, Human molecular genetics.

[1180]  T. Reinheckel,et al.  Ezrin turnover and cell shape changes catalyzed by proteasome in oxidatively stressed cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1181]  J. Rhodin,et al.  In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid. , 1997, Journal of submicroscopic cytology and pathology.

[1182]  George Kuriakose,et al.  The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages , 2003, Nature Cell Biology.

[1183]  T. Kupper,et al.  Inflammatory skin diseases, T cells, and immune surveillance. , 1999, The New England journal of medicine.

[1184]  T. Zimmers,et al.  Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.

[1185]  A. Goldberg,et al.  Protein degradation and the generation of MHC class I-presented peptides. , 2002, Advances in immunology.

[1186]  K. Moremen,et al.  Human EDEM2, a novel homolog of family 47 glycosidases, is involved in ER-associated degradation of glycoproteins. , 2005, Glycobiology.

[1187]  E. Messing,et al.  Ubiquitination of a Novel Deubiquitinating Enzyme Requires Direct Binding to von Hippel-Lindau Tumor Suppressor Protein* , 2002, The Journal of Biological Chemistry.

[1188]  S. Kato,et al.  A2E, a Pigment of the Lipofuscin of Retinal Pigment Epithelial Cells, Is an Endogenous Ligand for Retinoic Acid Receptor* , 2008, Journal of Biological Chemistry.

[1189]  I. Komuro,et al.  Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases. , 2004, Current pharmaceutical design.

[1190]  Jingzhi Li,et al.  Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex. , 2006, The Biochemical journal.

[1191]  Keiji Tanaka,et al.  4-Hydroxy-2-nonenal-mediated Impairment of Intracellular Proteolysis during Oxidative Stress , 1999, The Journal of Biological Chemistry.

[1192]  S. W. Davies,et al.  Filamentous nerve cell inclusions in neurodegenerative diseases , 1998, Current Opinion in Neurobiology.

[1193]  G. Clawson Protease inhibitors and carcinogenesis: a review. , 1996, Cancer investigation.

[1194]  G. Pasinetti,et al.  Phosphorylation of tau at THR212 and SER214 in human neuronal and glial cultures: The role of AKT , 2004, Neuroscience.

[1195]  Qing Yang,et al.  Proteasome subunit LMP2 is required for matrix metalloproteinase‐2 and ‐9 expression and activities in human invasive extravillous trophoblast cell line , 2006, Journal of cellular physiology.

[1196]  J. Papaconstantinou,et al.  Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. , 2008, Biochemical and biophysical research communications.

[1197]  G. Ailawadi,et al.  Increased MMP-9 expression and activity by aortic smooth muscle cells after nitric oxide synthase inhibition is associated with increased nuclear factor-kappaB and activator protein-1 activity. , 2004, The Journal of surgical research.

[1198]  S. W. Lin,et al.  Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. , 1990, The Journal of biological chemistry.

[1199]  E. Hartmann,et al.  A role for mammalian Ubc6 homologues in ER-associated protein degradation. , 2002, Journal of cell science.

[1200]  James B. Mitchell,et al.  Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF‐κB , 2000, Head & neck.

[1201]  Adrianna Skoneczna,et al.  The spectrum of spontaneous mutations caused by deficiency in proteasome maturase Ump1 in Saccharomyces cerevisiae , 2007, Current Genetics.

[1202]  M. Crompton Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. , 2000, Current opinion in cell biology.

[1203]  E. J. Simon,et al.  A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor , 2006, Brain Research.

[1204]  M. Gilca,et al.  The oxidative hypothesis of senescence. , 2007, Journal of postgraduate medicine.

[1205]  Chunjiang Tan,et al.  Inhibition of the ubiquitin-proteasome system: a new avenue for atherosclerosis , 2006, Clinical chemistry and laboratory medicine.

[1206]  A. Terman,et al.  Proteasome Inhibition Enhances Lipofuscin Formation , 2002, Annals of the New York Academy of Sciences.

[1207]  S. Wolff,et al.  Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose , 1990, Diabetes.

[1208]  M. Chopp,et al.  Postischemic (6-Hour) Treatment With Recombinant Human Tissue Plasminogen Activator and Proteasome Inhibitor PS-519 Reduces Infarction in a Rat Model of Embolic Focal Cerebral Ischemia , 2001, Stroke.

[1209]  E. Mazzon,et al.  Beneficial effects of Mn(III)tetrakis (4‐benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan‐induced shock , 1999, British journal of pharmacology.

[1210]  K. Prasad,et al.  Risk Factors for Alzheimer’s Disease: Role of Multiple Antioxidants, Non-Steroidal Anti-inflammatory and Cholinergic Agents Alone or in Combination in Prevention and Treatment , 2002, Journal of the American College of Nutrition.

[1211]  H. Ploegh,et al.  Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic beta-subunits. , 2001, Chemistry & biology.

[1212]  A. Goldberg,et al.  The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. , 2001, Molecular cell.

[1213]  M. Baptista,et al.  Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. , 2005, Brain : a journal of neurology.

[1214]  O. Arancio,et al.  Alpha-synuclein: between synaptic function and dysfunction. , 2003, Histology and histopathology.

[1215]  T. Sommer,et al.  Ubx2 links the Cdc48 complex to ER-associated protein degradation , 2005, Nature Cell Biology.

[1216]  Ann Richmond,et al.  Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition , 2004, Cancer Research.

[1217]  A. Ichihara,et al.  cDNA cloning of rat proteasome subunit RC10‐II, assumed to be responsible for trypsin‐like catalytic activity , 1993, FEBS letters.

[1218]  Masaki Yasukawa,et al.  Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells1 , 2001, The Journal of Immunology.

[1219]  Jeffrey W Jutai,et al.  Age-related macular degeneration and low-vision rehabilitation: a systematic review. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[1220]  U. Brunk,et al.  The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. , 2002, European journal of biochemistry.

[1221]  Santhosh K. P. Kumar,et al.  Ubiquitin-mediated degradation of active Src tyrosine kinase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1222]  N. Osna,et al.  Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. , 2003, Biochemical pharmacology.

[1223]  J. Massagué,et al.  Ubiquitin-dependent degradation of TGF-β-activated Smad2 , 1999, Nature Cell Biology.

[1224]  Gabriella M. A. Forte,et al.  Sec61p Is Required for ERAD-L , 2008, Journal of Biological Chemistry.

[1225]  J. Hainfeld,et al.  Binding of Amyloid β Protein to the 20 S Proteasome* , 1997, The Journal of Biological Chemistry.

[1226]  B. Friguet,et al.  Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. , 1996, Archives of biochemistry and biophysics.

[1227]  L. Nanney,et al.  Increased epidermal growth factor receptors in melanocytic lesions. , 1992, Journal of the American Academy of Dermatology.

[1228]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[1229]  K. Davies,et al.  Protein degradation as an index of oxidative stress. , 1990, Methods in enzymology.

[1230]  V. Herzog,et al.  Endoplasmic reticulum-associated degradation: exceptions to the rule. , 2004, European journal of cell biology.

[1231]  Bertrand Friguet,et al.  The ubiquitin–proteasome system at the crossroads of stress-response and ageing pathways: A handle for skin care? , 2006, Ageing Research Reviews.

[1232]  P. Lasch,et al.  Hydrogen Peroxide-induced Structural Alterations of RNase A* , 2001, The Journal of Biological Chemistry.

[1233]  L. Millen,et al.  Conformational Remodeling of Proteasomal Substrates by PA700, the 19 S Regulatory Complex of the 26 S Proteasome* , 2002, The Journal of Biological Chemistry.

[1234]  L. Neckers,et al.  Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors. , 2000, Biochemical pharmacology.

[1235]  J. Adams Development of the proteasome inhibitor PS-341. , 2002, The oncologist.

[1236]  G. Buttin,et al.  Twelve genes, including the unassigned proteasome ζ subunit gene, ordered within the human 1p13 region , 1998, Mammalian Genome.

[1237]  G. Evan,et al.  Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. , 2007, Cancer cell.

[1238]  H. Wiśniewski,et al.  Lipopigment in the aging brain. , 1988, American journal of medical genetics. Supplement.

[1239]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[1240]  N. Shastri,et al.  ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum , 2002, Nature.

[1241]  Wolfgang Baumeister,et al.  The ATP-dependent HslVU protease from Escherichia coli is a four-ring structure resembling the proteasome , 1997, Nature Structural Biology.

[1242]  T. Ruzicka,et al.  Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. , 2005, Arthritis and rheumatism.

[1243]  D. Harman Free radical theory of aging. , 1992, Triangle; the Sandoz journal of medical science.

[1244]  W. Markesbery,et al.  Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.

[1245]  H. Qing,et al.  Degradation of nicastrin involves both proteasome and lysosome , 2007, Journal of neurochemistry.

[1246]  J. Sjöstrand,et al.  Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract , 2003, Current eye research.

[1247]  A. Brice,et al.  Spinocerebellar ataxia 17 (SCA17) and Huntington’s disease-like 4 (HDL4) , 2008, The Cerebellum.

[1248]  Yong Xia,et al.  Proteasome Inhibition Down-regulates Endothelial Nitric-oxide Synthase Phosphorylation and Function* , 2006, Journal of Biological Chemistry.

[1249]  Stavros J. Baloyannis,et al.  Mitochondrial alterations Alzheimer's disease , 2004, American journal of Alzheimer's disease and other dementias.

[1250]  A. Asai,et al.  Proteasome Inhibitors Induce Cytochrome c–Caspase-3-Like Protease-Mediated Apoptosis in Cultured Cortical Neurons , 2000, The Journal of Neuroscience.

[1251]  T. Welling,et al.  Adenoviral-mediated gene transfer of ICP47 inhibits major histocompatibility complex class I expression on vascular cells in vitro. , 2000, Journal of vascular surgery.

[1252]  E. Strickland,et al.  Recognition of Misfolding Proteins by PA700, the Regulatory Subcomplex of the 26 S Proteasome* , 2000, The Journal of Biological Chemistry.

[1253]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[1254]  F. Holz,et al.  [Age-related macular degeneration. 1. Epidemiology, pathogenesis and differential diagnosis]. , 1996, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[1255]  Simon C Watkins,et al.  The Hsp40 Molecular Chaperone Ydj1p, Along With the Protein Kinase C Pathway, Affects Cell-Wall Integrity in the Yeast Saccharomyces cerevisiae , 2007, Genetics.

[1256]  H. Lehrach,et al.  Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. , 2001, Molecular biology of the cell.

[1257]  A. Rosenblatt,et al.  Neuropsychiatry of Huntington's disease and other basal ganglia disorders. , 2000, Psychosomatics.

[1258]  Wei Ping Wang,et al.  Inhibition of proteasome function induced apoptosis in gastric cancer , 2001 .

[1259]  A. Johnsen,et al.  The human proteasome subunit HsN3 is located in the inner rings of the complex dimer. , 1995, Journal of molecular biology.

[1260]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[1261]  Bruce Futcher,et al.  Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins , 1995, Nature.

[1262]  U. Lendahl,et al.  Pen-2 Is Sequestered in the Endoplasmic Reticulum and Subjected to Ubiquitylation and Proteasome-mediated Degradation in the Absence of Presenilin* , 2004, Journal of Biological Chemistry.

[1263]  S. Wolff,et al.  Protein glycation and oxidative stress in diabetes mellitus and ageing. , 1991, Free radical biology & medicine.

[1264]  M. Jasin,et al.  BRCA2 is required for homology-directed repair of chromosomal breaks. , 2001, Molecular cell.

[1265]  P. Riederer,et al.  Understanding Parkinson's disease. , 1997, Scientific American.

[1266]  P. Williamson,et al.  The Hsp70 member, Ssa1, acts as a DNA‐binding transcriptional co‐activator of laccase in Cryptococcus neoformans , 2006, Molecular microbiology.

[1267]  L. Klotz,et al.  Singlet oxygen mediates the activation of JNK by UVA radiation in human skin fibroblasts , 1997, FEBS letters.

[1268]  B. Friguet,et al.  Proteasome inactivation upon aging and on oxidation-effect of HSP 90 , 1997, Molecular Biology Reports.

[1269]  A. Goldberg,et al.  Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. , 1999, Molecular cell.

[1270]  C. Pickart,et al.  Specificity of the Ubiquitin Isopeptidase in the PA700 Regulatory Complex of 26 S Proteasomes* , 1997, The Journal of Biological Chemistry.

[1271]  M. Glickman,et al.  Proteasome Disassembly and Downregulation Is Correlated with Viability during Stationary Phase , 2003, Current Biology.

[1272]  I. Nemere,et al.  The ERp57/GRp58/1,25D3-MARRS receptor: multiple functional roles in diverse cell systems. , 2007, Current medicinal chemistry.

[1273]  K. Reuhl,et al.  Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthaldialdehyde-induced histofluorescence. , 1991, Toxicology and applied pharmacology.

[1274]  A. Silman,et al.  Scleroderma--demographics and survival. , 1997, The Journal of rheumatology. Supplement.

[1275]  R. Bold,et al.  Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. , 2001, The Journal of surgical research.

[1276]  A. Haas,et al.  Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. , 1980, The Journal of biological chemistry.

[1277]  W. Green,et al.  IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.

[1278]  D. Hood,et al.  Mitochondrial biogenesis and the role of the protein import pathway. , 2003, Medicine and science in sports and exercise.

[1279]  D. McConkey,et al.  The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenografts. , 2004, Molecular cancer therapeutics.

[1280]  P. Beer-Romero,et al.  Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[1281]  R. Schekman,et al.  Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes , 1995, Cell.

[1282]  A. Goldberg,et al.  Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[1283]  S. Matsufuji,et al.  Involvement of the proteasome and antizyme in ornithine decarboxylase degradation by a reticulocyte lysate. , 1993, The Biochemical journal.

[1284]  M. Hochstrasser,et al.  Membrane Topology of the Yeast Endoplasmic Reticulum-localized Ubiquitin Ligase Doa10 and Comparison with Its Human Ortholog TEB4 (MARCH-VI)* , 2006, Journal of Biological Chemistry.

[1285]  A. Goldberg,et al.  What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? , 2001, Current opinion in clinical nutrition and metabolic care.

[1286]  H. Fernandez,et al.  Monamine Oxidase Inhibitors: Current and Emerging Agents for Parkinson Disease , 2007, Clinical neuropharmacology.

[1287]  K. Früh,et al.  Rhesus Cytomegalovirus Contains Functional Homologues of US2, US3, US6, and US11 , 2005, Journal of Virology.

[1288]  R. Vender,et al.  Cystic Fibrosis Lung Disease in Adult Patients , 2008, Postgraduate medicine.

[1289]  Y. Okawa,et al.  Calpain inhibitor causes accumulation of ubiquitinated P-glycoprotein at the cell surface: possible role of calpain in P-glycoprotein turnover. , 1999, International journal of oncology.

[1290]  H. Gilbert,et al.  Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. , 1994, The Journal of biological chemistry.

[1291]  C. Barlowe,et al.  Sel1p/Ubx2p Participates in a Distinct Cdc48p‐Dependent Endoplasmic Reticulum‐Associated Degradation Pathway , 2006, Traffic.

[1292]  W. Kaelin,et al.  Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[1293]  K. Davies,et al.  Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. , 1987, The Journal of biological chemistry.

[1294]  R. Perez-soler,et al.  Reactive Oxygen Species Generation and Mitochondrial Dysfunction in the Apoptotic Response to Bortezomib, a Novel Proteasome Inhibitor, in Human H460 Non-small Cell Lung Cancer Cells* , 2003, Journal of Biological Chemistry.

[1295]  P. Ponka Hereditary Causes of Disturbed Iron Homeostasis in the Central Nervous System , 2004, Annals of the New York Academy of Sciences.

[1296]  C. Slaughter,et al.  Formation of Proteasome-PA700 Complexes Directly Correlates with Activation of Peptidase Activity , 1998, Microscopy and Microanalysis.

[1297]  P. Kloetzel,et al.  The proteasome inhibitor PI31 competes with PA28 for binding to 20S proteasomes , 1999, FEBS letters.

[1298]  B. Müller-Myhsok,et al.  Early onset of severe familial amyotrophic lateral sclerosis with a SOD-1 mutation: potential impact of CNTF as a candidate modifier gene. , 2002, American journal of human genetics.

[1299]  K. Davies,et al.  Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome. , 1994, Archives of biochemistry and biophysics.

[1300]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors , 2003, Journal of Biological Chemistry.

[1301]  T. Kuwana,et al.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.

[1302]  K. Scherrer,et al.  The prosomes (multicatalytic proteinases; proteasomes) and their relationship to the untranslated messenger ribonucleoproteins, the cytoskeleton, and cell differentiation. , 1994, Progress in nucleic acid research and molecular biology.

[1303]  Yixian Zheng,et al.  The Cdc48/p97-Ufd1-Npl4 Complex: Its Potential Role in Coordinating Cellular Morphogenesis During the M-G1 Transition , 2004, Cell cycle.

[1304]  E. Hol,et al.  Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation , 2002, The Journal of cell biology.

[1305]  Shih-Yi Lin,et al.  Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: potential role of TNF-alpha. , 2005, American journal of physiology. Endocrinology and metabolism.

[1306]  Lance F. Barton,et al.  Immune Defects in 28-kDa Proteasome Activator γ-Deficient Mice1 , 2004, The Journal of Immunology.

[1307]  The Selective Proteasome Inhibitors Lactacystin and Epoxomicin Can Be Used to Either Up- or Down-Regulate Antigen Presentation at Nontoxic Doses1 , 2000, The Journal of Immunology.

[1308]  D. Harman,et al.  Lipofuscin and ceroid formation: the cellular recycling system. , 1989, Advances in experimental medicine and biology.

[1309]  H. Qing,et al.  Ubiquitin–proteasome pathway mediates degradation of APH‐1 , 2006 .

[1310]  R. Hampton,et al.  Cue1p Is an Activator of Ubc7p E2 Activity in Vitro and in Vivo* , 2008, Journal of Biological Chemistry.

[1311]  D. Pellman,et al.  Deubiquitinating enzymes: a new class of biological regulators. , 1998, Critical reviews in biochemistry and molecular biology.

[1312]  A. Bruce-Keller,et al.  LMP2 knock-out mice have reduced proteasome activities and increased levels of oxidatively damaged proteins. , 2006, Antioxidants & redox signaling.

[1313]  S. Ōmura,et al.  Proteasome-dependent regulation of p21WAF1/CIP1 expression. , 1996, Biochemical and biophysical research communications.

[1314]  V. Ravindranath,et al.  Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death‐associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by α‐lipoic acid , 2007 .

[1315]  L. Dick,et al.  Mechanistic Studies on the Inactivation of the Proteasome by Lactacystin in Cultured Cells* , 1997, The Journal of Biological Chemistry.

[1316]  M. Scheffner,et al.  The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 , 1993, Cell.

[1317]  J. Dobson,et al.  Beta-adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation. , 2003, American journal of physiology. Heart and circulatory physiology.

[1318]  U. Brunk,et al.  Lipofuscin: mechanisms of age-related accumulation and influence on cell function. , 2002, Free radical biology & medicine.

[1319]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[1320]  H. Band,et al.  Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. , 1998, International immunology.

[1321]  C. Ross,et al.  Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant α-synuclein enhances H2O2- and Sin-1-induced cell death , 2007, Neurobiology of Aging.

[1322]  W. J. Cromartie,et al.  Arthritis in rats after systemic injection of streptococcal cells or cell walls , 1977, The Journal of experimental medicine.

[1323]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[1324]  A. Vitiello,et al.  Impaired immunoproteasome assembly and immune responses in PA28-/- mice. , 1999, Science.

[1325]  K. Nakanishi,et al.  A2E, a fluorophore of RPE lipofuscin, can destabilize membrane. , 2006, Advances in experimental medicine and biology.

[1326]  R. Busse,et al.  Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. , 1997, Hypertension.

[1327]  R. Roos,et al.  Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases , 2007, Molecular and Cellular Neuroscience.

[1328]  G. Bartosz,et al.  Oxidative modifications of protein structures. , 2000, Advances in clinical chemistry.

[1329]  C. Franceschi,et al.  Fibroblast cultures from healthy centenarians have an active proteasome , 2000, Experimental Gerontology.

[1330]  A. Goldberg,et al.  Interferon-γ Can Stimulate Post-proteasomal Trimming of the N Terminus of an Antigenic Peptide by Inducing Leucine Aminopeptidase* , 1998, The Journal of Biological Chemistry.

[1331]  C. Hill,et al.  Characterization of Recombinant REGα, REGβ, and REGγ Proteasome Activators* , 1997, The Journal of Biological Chemistry.

[1332]  A Hofman,et al.  Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. , 1998, Archives of ophthalmology.

[1333]  K. Tanaka,et al.  Sequence analyses and inter-species comparisons of three novel human proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential proteolytic active-site residues. , 1994, Biochimica et biophysica acta.

[1334]  J. W. Margolis,et al.  Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor. , 1995, Archives of biochemistry and biophysics.

[1335]  Jiangping Wu On the Role of Proteasomes in Cell Biology and Proteasome Inhibition as a Novel Frontier in the Development of Immunosuppressants , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[1336]  K. Mulder,et al.  Modulation of Ubc4p/Ubc5p-Mediated Stress Responses by the RING-Finger-Dependent Ubiquitin-Protein Ligase Not4p in Saccharomyces cerevisiae , 2007, Genetics.

[1337]  Dean P. Jones Redox potential of GSH/GSSG couple: assay and biological significance. , 2002, Methods in enzymology.

[1338]  K Tanaka,et al.  Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats. , 2000, Biochemical and biophysical research communications.

[1339]  D. S. Lind,et al.  Nuclear factor-κB is upregulated in colorectal cancer , 2001 .

[1340]  J. Scheller,et al.  IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts , 2008, Journal of Neuroimmunology.

[1341]  Benjamin Geiger,et al.  Down-Regulation of β-Catenin by Activated p53 , 2001, Molecular and Cellular Biology.

[1342]  L. Formigli,et al.  Expression of E-selectin in ischemic and reperfused human skeletal muscle. , 1995, Ultrastructural pathology.

[1343]  K. Lim,et al.  Autophagy-mediated clearance of aggresomes is not a universal phenomenon. , 2008, Human molecular genetics.

[1344]  C. Olanow,et al.  Selective loss of 20S proteasome α-subunits in the substantia nigra pars compacta in Parkinson's disease , 2002, Neuroscience Letters.

[1345]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[1346]  K. Ferrell,et al.  Purification of an 11 S regulator of the multicatalytic protease. , 1992, The Journal of biological chemistry.

[1347]  James M. Roberts,et al.  Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome. , 2007, Molecular cell.

[1348]  A. Wandinger-Ness,et al.  The Proteasome α-Subunit XAPC7 Interacts Specifically with Rab7 and Late Endosomes* , 2004, Journal of Biological Chemistry.

[1349]  S. French,et al.  The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation. , 2004, Experimental and molecular pathology.

[1350]  P. Kloetzel,et al.  PI31 is a modulator of proteasome formation and antigen processing , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1351]  H. Lehrach,et al.  Linkage of TATA-binding protein and proteasome subunit C5 genes in mice and humans reveals synteny conserved between mammals and invertebrates. , 1997, Genomics.

[1352]  K. Satoh,et al.  Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation , 2000, Brain pathology.

[1353]  Y. Ye Inaugural article : recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane , 2005 .

[1354]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[1355]  M. Orłowski,et al.  Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex. , 1992, Biochemistry.

[1356]  F. Blattner,et al.  Sequence analysis of four new heat-shock genes constituting the hslTS/ibpAB and hslVU operons in Escherichia coli. , 1993, Gene.

[1357]  K. Davies,et al.  Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome* , 2003, The Journal of Biological Chemistry.

[1358]  A. Chaffotte,et al.  Proteasome Inhibition in Glyoxal-treated Fibroblasts and Resistance of Glycated Glucose-6-phosphate Dehydrogenase to 20 S Proteasome Degradation in Vitro * , 2001, The Journal of Biological Chemistry.

[1359]  R. Hough,et al.  Purification of two high molecular weight proteases from rabbit reticulocyte lysate. , 1987, The Journal of biological chemistry.

[1360]  S. Bassnett On the mechanism of organelle degradation in the vertebrate lens. , 2009, Experimental eye research.

[1361]  Tobias Jung,et al.  The proteasome and its role in the degradation of oxidized proteins , 2008, IUBMB life.

[1362]  L. Pasquini,et al.  Relationship between β-amyloid degradation and the 26S proteasome in neural cells , 2003, Experimental Neurology.

[1363]  F. Shang,et al.  Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. , 2001, Experimental eye research.

[1364]  H. Nakase,et al.  Abnormal dentatorubral-pallidoluysian atrophy (DRPLA) protein complex is pathologically ubiquitinated in DRPLA brains. , 1999, Biochemical and biophysical research communications.